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Abstract
During early brain development, the subplate relays thalamocortical afferents.
Lesions to the subplate have been implicated in developmental abnormalities of cortical
GABAergic circuits. This thesis examined the effects of subplate lesions in the prefrontal
cortex of rats on the expression of GABA markers (parvalbumin and GAD67) and GABA
synapse maturation [potassium-chloride co transporter (KCC2) and sodium-potassiumchloride cotransporter (NKCC1)] with relevance to the characterization of a rat model for
schizophrenia. Lesions were made on postnatal day 1 (P1). Lesioned and control rats were
sacrificed between P5 and P90 and immunolabelled for parvalbumin, GAD67, KCC2, and
NKCC1. We found decreased parvalbumin expression in lesioned animals, validating our
subplate lesion model in impaired interneuron development. GAD67, KCC2, and NKCC1
levels were unchanged at all timepoints studied compared to control. Despite this, decreased
parvalbumin expression may alter cortical E/I balance, as previously seen in behavioral
abnormalities of this animal model.

Keywords
Neurodevelopment, subplate, GABA, prefrontal cortex, thalamocortical pathfinding,
schizophrenia, KCC2, NKCC1
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Summary for Lay Audience
During early brain development, the transient subplate layer of the brain relays
information from the thalamus to the cerebral cortex to guide the cortex in proper maturation.
Previously, studies have shown that damage to the subplate layer of the visual cortex early
during development results in abnormal levels of the KCC2 protein, which prevented the
maturation of inhibitory neurotransmitter signaling in the visual cortex. On the other hand,
damage to the subplate of the prefrontal cortex resulted in decreased levels of parvalbumin, a
calcium-binding protein critical for inhibitory neuronal function, as well as behavioral
abnormalities reminiscent of human schizophrenia. As schizophrenia has been proposed to be
a neurodevelopmental disorder exhibiting abnormal inhibitory neurotransmitter signaling in
the prefrontal cortex, we sought to damage the subplate layer of the prefrontal cortex of day
1-old rats. Using fluorescence techniques to detect protein levels in brain sections of
subplate-damaged and unaffected (control) rats, we found that subplate-damaged rats
exhibited lower levels of parvalbumin in the prefrontal cortex as expected, but KCC2
remained unchanged when compared to control animals. Further, KCC2 partner protein
NKCC1, and GAD67, the main enzyme responsible for synthesizing the brain’s inhibitory
neurotransmitter, was unchanged. Despite a lack of change in KCC2, NKCC1, and GAD67,
the change in parvalbumin protein levels of the prefrontal cortex may cause abnormalities in
the subplate-damaged brain, reflected in abnormal behavior of prefrontal subplate-damaged
rats. Thus, the subplate plays a significant role in cortical development, and prefrontal
subplate-damaged rats may serve as a potential animal model for the study of abnormal
inhibitory signaling seen in schizophrenia.
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Chapter 1

1

Introduction
Homeostatic balance between excitation and inhibition is central to brain

function. Inhibition in the brain is mediated by two neurotransmitters, namely, g-amino
butyric acid (GABA) and glycine. Both inhibitory neurotransmitters acting on their
respective receptors cause an influx of chloride ions leading to hyperpolarization of the
target membrane (Wilke et al. 2020). Chloride ion channels affected by both GABA and
glycine operate primarily based on the electrochemical gradient, the combinations of the
intra- and extra-cellular concentration gradients of chloride ions, and the voltage
difference across the plasma membrane (Wilke et al. 2020). Consequently, the
intracellular chloride concentration of neurons are very tightly regulated, and determine
the functioning of GABA and glycine receptors and ultimately the excitation/inhibition
(E/I) balance (Payne 1997). The ability of a neuron to maintain a basal chloride ion
concentration is controlled primarily by two membrane transporters, potassium (K)
chloride co-transporter (KCC2) and sodium (Na) potassium (K) chloride co-transporter
(NKCC1). KCC2 extrudes chloride ions while NKCC1 allows for influx of chloride ions
(Ben-Ari et al. 1989). Evidence indicates that KCC2 function is dependent on neuronal
activity and is developmentally regulated (Ben-Ari et al. 1989; Ben-Ari et al. 2012).
It is well known that during development both GABA and glycine exert excitatory
effects along with glutamate, facilitating migration of cortical neurons (Owens et al.
1999; Cuzon et al. 2006; Inada et al. 2011). Termination of interneuron migration into the
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developing cerebral cortex coincides with the upregulation of KCC2 in cortical neurons,
as well as with a switch in GABA and glycine effects from depolarization to
hyperpolarization of target neurons (Bortone and Polleux 2009). In rodents, interneuron
migration continues until the end of the first postnatal week, which coincides with
increased levels of KCC2 in cortical neurons (Wang and Kriegstein 2011). Interestingly,
ablation of the subplate layer, a transient layer of early generated cortical neurons that
occupy deep to the developing cerebral cortical layers and superficial to the developing
white matter, in primary visual and somatosensory cortices resulted in a delay in the
developmental upregulation of KCC2 and emergence of inhibitory function of GABA in
layer IV of the cortices (Kanold and Shatz 2006; Kanold 2009).
In postmortem studies of the prefrontal cortex (PFC) of schizophrenia patients,
reduced KCC2 levels, altered expression of enzymes and signaling molecules indicating
reduced inhibitory function of GABA, and abnormal distribution of GABAergic
interneurons are described. Accordingly, altered GABA function and E/I imbalance have
been proposed as central mechanisms underlying cognitive abnormalities of
schizophrenia (Hoftman et al. 2017; Schoonover et al. 2020). Previously, our laboratory
has characterized a putative rat model showing multiple structural and behavioral features
remniscent of human schizophrenia following neonatal ablation of the subplate of the
developing PFC (Rajakumar et al. 2004; Lazar et al. 2008; Desai et al. 2018). In primary
sensory cortices, ablation of the developing subplate layer affected KCC2 expression and
GABA function in layer IV, the thalamocortical recepient layer in primary sensory
cortices (Kanold and Shatz 2006), causally linking the subplate lesion and developmental
impairment of cortical interneurons. However, it is not clear whether ablation of the
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developing subplate layer would cause changes in KCC2 and GABA abnormalities in the
PFC, a multimodal association cortex where layer IV is virtually indistinguishable and
thalamocortical innervation is more widespread. Nonetheless, our laboratory has recently
demonstrated that neonatal ablation of the subplate layer in the developing PFC resulted
in altered positioning of GABA interneurons and reduced levels of GABA neuronal
markers (Desai et al., 2018).
Therefore, I hypothesized that a neonatal ablation of the subplate layer of the
developing PFC will result in altered developmental patterns of KCC2 and NKCC1
protein levels and abnormalities in GABA interneurons of the PFC.
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Chapter 2

2

Literature Review

2.1 Cerebral Cortical Development and Interneurons
The cerebral cortex consists of two main classes of neurons, excitatory projection
neurons and inhibitory interneurons, which use glutamate and GABA as their principal
neurotransmitters, respectively. Inhibitory interneurons comprise about 20% of all
cortical neurons and are classically grouped based on their intrinsic membrane properties
and expression of calcium-binding proteins into four major classes: (1) fast-spiking
parvalbumin (PV)-containing basket and chandelier cells; (2) somatostatin (SST)containing interneurons with burst-spiking properties; (3) calretinin (CR)- and
vasoactive-intestinal polypeptide (VIP)-expressing rapidly adapting interneurons; and (4)
rapidly adapting interneurons that express neuropeptide Y (NPY) (Gelman and Marín
2010).
The cerebral cortex comprises primary motor and sensory areas, unimodal
association areas, as well as multimodal association cortices such as the PFC. Primary
sensory cortices are characterized by a thick layer IV that not only serves as the main
recipient layer for thalamocortical fibers but also contains the majority of PV-containing
basket cells. In contrast, the PFC does not have a discernible layer IV, has more
widespread distribution of PV-containing basket cells, and its thalamic afferents are not
concentrated to a single layer (Gelman and Marín 2010). PV-containing basket cells
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receive a large contingent of direct thalamic inputs, are fast-firing and play a significant
role in functional synchronization of cortical neuronal activity leading to cortical
oscillation and E/I balance of the cortical network (Markram et al. 2004; GonzálezBurgos et al. 2005). The E/I balance and neuronal oscillation patterns are considered
central to cognition and abnormalities in these functions and associated abnormalities of
inhibitory interneurons, particularly in PV-containing basket cells, are described in
several neurological disorders such as epilepsy, autism, and schizophrenia (Moore et al.
2017).
The assembly and wiring of cortical neuronal circuits require spatially and
temporally coordinated events that are guided by intrinsic genetic programming, neuronal
activity, and a permissive cellular environment. Interneurons originate from the
embryonic subpallium that comprises lateral, medial, and caudal ganglionic eminences
(Lim et al. 2018). Among these, cortical interneurons are primarily derived from the
medial and caudal ganglionic eminences. Converging evidence indicates that about 65%
of neurons that originate from the medial ganglionic eminence (MGE) become PVcontaining interneurons, while the remaining ~35% form SST-containing interneurons
(Gelman and Marín 2010; Hu et al. 2017). In addition to the spatial regulation, the
development of interneurons is temporally regulated. For example, in the MGE, SST
interneurons are generated prior to the production of PV interneurons, which are
produced at more constant rates than SST interneurons and occur throughout
neurogenesis (Miyoshi et al. 2007; Inan et al. 2012; Hu et al. 2017).
From ganglionic eminences, the interneurons first migrate tangentially toward the
cerebral cortex through the subventricular zone and subplate layer. Each cohort of
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newborn neurons spends approximately 48 hours migrating through the subcortical zone
before entering the cortical plate. Arrival of interneurons at the subcortical zone of their
respective cortical area through tangential migration coincides with the arrival of their
partner excitatory projection (pyramidal) neurons to their final laminar positions in the
developing cortical plate (López-Bendito et al. 2008). From the subcortical zone of the
respective cortical areas, the interneurons then turn to migrate radially to their destined
cortical layers (Lim et al. 2018). In rodents, radial migration of interneurons continues
into the first postnatal week (Hu et al. 2017). As the cerebral cortex develops in an insideout fashion, earlier born interneurons are positioned in the deeper layers, while later-born
neurons establish their final positions in the upper layers of the cortex (Valcanis and Tan
2003; Yamada et al. 2004; Hu et al. 2017).
Overwhelming evidence indicates that the cues provided by the developing
cortical plate play a critical role in the final disposition of interneurons and in the
establishment of their connections. Excitatory drive and associated calcium fluxes
affecting the movement of the actin cytoskeleton of interneurons are provided by
glutamatergic inputs from surrounding pyramidal neurons and axons of subplate and
thalamocortical neurons, playing an important role in the migration of interneurons
within the developing cortex (Wong et al. 2018). For example, disrupting the normal
distribution of cortical pyramidal neurons resulted in an abnormal laminar patterning of
PV and SST interneurons (Lodato et al. 2011; Wong et al. 2018). Similarly, increasing
pyramidal cell activity during the first postnatal week in mice resulted in an increase in
laminar-specific density of PV interneurons, while decreasing pyramidal cell activity
resulted in a lower density of PV interneurons (Wong et al. 2018). Further, cortical
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pyramidal cells, which arrive at the cortical plate earlier than interneurons, start
expressing neuregulin 3 (Nrg3) which produces an important short-range chemoattractive effect on MGE-derived interneurons. Deletion of Nrg3 from developing
pyramidal neurons in the cortex disrupted laminar distribution, but not overall number, of
interneurons (Bartolini et al. 2017). On the other hand, overexpression of Nrg3
accelerated the invasion of MGE-born interneurons into the cortical plate, providing
further support for pyramidal neuronal influence on laminar distribution patterning of
interneurons (Bartolini et al. 2017). In addition to the glutamatergic inputs, migrating
interneurons express GABA and glycine and their cognate receptors, GABAA and glycine
receptors (Avila et al. 2013). GABA and glycine acting on GABAA and glycine receptors
results in the depolarization of target sites aiding the glutamatergic effect, and together
provide the necessary calcium spikes required for the cytoskeletal dynamics of neuronal
migration (Owens et al. 1999; Cuzon et al. 2006; Inada et al. 2011; Avila et al. 2013).
By the end of the first postnatal week in rodents, MGE-derived interneurons
upregulate expression of KCC2, a chloride co-transporter protein (Dzhala et al. 2005;
Bortone and Polleux 2009). The upregulation of KCC2 in interneurons, which seems to
be a conserved intrinsic program among all interneuron types, drastically reduces the
frequency of intracellular calcium transients in response to GABA and glycine. This
results in the pausing of migrating MGE-born interneurons, eventually halting neuronal
migration (Bortone and Polleux 2009; Miyoshi and Fishell 2011). The hyperpolarizing
effect of KCC2 upon activation of GABAA receptors is sufficient to terminate neuronal
migration (Bortone and Polleux 2009). Convincing evidence indicates that termination of
interneuron migration in the cerebral cortex coincides with increased levels of KCC2 in
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cortical neurons, as well as with a switch in GABA effects from depolarization to
hyperpolarization of target neurons (Bortone and Polleux 2009).
Pruning of synapses and programmed cell death are important for creating an
optimal micro-circuitry of the cortical network and function. Between postnatal days (P)
2 and P5 in rodents, the total number of excitatory neurons declines in all layers of the
neocortex, then remains consistent into adulthood. Meanwhile, inhibitory interneurons
are steady in number until the end of the first postnatal week, followed by ~30% decrease
early during the second postnatal week, then remains consistent into adulthood (Wong et
al. 2018). In summary, a wave of pyramidal cell death (P2-P7) is followed by interneuron
death (P7-P10). Increasing pyramidal neuronal activation onto interneurons during the
normal period of interneuron death prevented the death of interneurons, leading to a
significant increase in the density of PV interneurons at P21 in the primary
somatosensory and motor cortex across all layers. In contrast, dampening the activity of
pyramidal cells during P7-10 decreased the density of PV interneurons at P21 across all
layers of the somatosensory and motor cortex (Wong et al. 2018). Thus, interneuron
survival seems to be, in part, reliant on activity-dependent mechanisms at least in primary
sensory and motor cortices.
Once in their final laminar positions, interneurons not only provide extensive
inputs within their respective functional columnar units, but also provide highly branched
axonal collaterals laterally across columns in the cortex allowing for integration, lateral
inhibition and maintenance of the E/I balance (Markram et al. 2004). While glutamatergic
excitatory preterminal axons seem to be geometrically uncorrelated with their
postsynaptic targets, inhibitory axons are highly branched, convoluted, and are
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geometrically correlated with their postsynaptic sites (Kalisman et al. 2005; Stepanyants
and Chklovskii 2005). This pattern of synaptic arrangement is attributed to providing a
tighter regulation of E/I balance in the cortical network. However, this intricate
arborization and innervation of axon terminals of interneurons is not completed until
adolescence, leaving a window of opportunity where GABAergic interneurons can be
affected by activity and environmental stressors. For example, animals deprived of
sensory experience and thalamocortical inputs exhibit a delayed GABAergic maturation
and abnormal functioning in their sensory cortices (Micheva and Beaulieu 1997; Morales
et al. 2002; Chattopadhyaya et al. 2004; Jiao et al. 2006; Deng et al. 2017). Thus,
thalamic input and activity plays a significant role in the eventual target finding,
innervation, and maturation of cerebral cortical interneurons.

2.2 Maturation of the Cerebral Cortical GABA System
Fast synaptic inhibition in the brain is predominantly mediated by GABAA
receptors, a group of ligand-gated chloride ion channel proteins, whose ultimate function
is mainly dependent on the intracellular chloride ion concentration. During early stages of
brain development, neurons have a high intracellular chloride ion concentration, resulting
in a depolarizing (excitatory) response to GABAA receptor activation. On the other hand,
in the mature brain, neurons have a lower intracellular chloride concentration, which
results in a hyperpolarizing (inhibitory) GABAergic response (Ben-Ari et al. 1989;
Rivera et al. 1999; Ben-Ari 2014). The intracellular chloride concentration is critically
modulated by two chloride co-transporter proteins NKCC1 and KCC2, which direct
chloride inward and outward, respectively (Sánchez Fernández and Loddenkemper 2014;
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Moore et al. 2017). At early developmental periods, higher NKCC1:KCC2 expression
ratios coincide with a depolarizing GABAA receptor response. With maturation, KCC2
expression is upregulated, resulting in lower NKCC1:KCC2 expression ratios that
coincide with a hyperpolarizing GABAA receptor response in the adult brain (Yamada et
al. 2004; Kanold 2009; Hyde et al. 2011; Moore et al. 2017).
During the first postnatal week in rats, NKCC1 expression is robust in cortical
neurons (Dzhala et al. 2005). Levels of NKCC1 protein continue to increase during the
first two postnatal weeks and are expressed at significantly higher levels during this age
as compared to adult rats (~14 fold higher during the first two postnatal weeks) and
plateau around the beginning of the third postnatal week, remaining steady into adulthood
(Gerald H. Clayton et al. 1998; Wang et al. 2002). On the other hand, KCC2 begins
appearing in the rodent cerebral cortex just prior to birth. During the first postnatal week,
KCC2 expression levels are relatively low, then rapidly increase by the end of the first
postnatal week, continuing to rise until postnatal week 3, remaining relatively consistent
at this level into adulthood (Gerald H. Clayton et al. 1998; Wang et al. 2002; Stein et al.
2004; Dzhala et al. 2005; Kovács et al. 2014). Interestingly, upregulation of KCC2
mRNA levels in the cortex at the end of first postnatal week was found to correlate with
the onset of the GABA switch from depolarizing to hyperpolarizing (Rivera et al. 1999;
Vu et al. 2000). This GABA switching has been delayed in animal models during
development following maternal immune activation (Corradini et al. 2018), maternal
separation (Furukawa et al. 2017), and ablation of subplate in the primary visual cortex
(Kanold and Shatz 2006), which also resulted in a delayed upregulation of KCC2.
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KCC2 belongs to the cation-chloride co-transporter superfamily that comprises 9
members including KCC1, KCC3, KCC4 and NKCC1. KCC2 is exclusively expressed
by neurons in mammals. KCC2 knock out mice show E/I imbalance, widespread synaptic
and network abnormalities and manifest seizures (Woo et al. 2002). As mentioned
previously, the timing of increased KCC2 mRNA and protein levels in the developing
cerebral cortex and the GABAA receptor activity switch from depolarization to
hyperpolarization coincides. It is not clear what triggers the upregulation of KCC2
expression during development. Activity-dependent signaling including a role of brainderived neurotropic factor (BDNF) upregulating KCC2 expression via Egr4 transcription
factor has been proposed (Ludwig et al. 2011). Interestingly, the KCC2 protein shows an
extreme tendency to oligomerize both in neuronal cytoplasm in vivo and during protein
extraction for western blotting, resulting in inconsistent bands in western blots (Medina et
al. 2014). Although increased expression of mRNA and proteins of KCC2 are likely to be
more important during cortical development, function of KCC2 has been shown to be
highly modulated by several posttranslational events, including dimerization, trafficking,
plasma membrane insertion, phosphorylation status of KCC2, and internalization
(Medina et al. 2014; Côme et al. 2019). Interestingly, dimerization of KCC2 is proposed
as an essential step for membrane insertion, which is facilitated by BDNF (Blaesse et al.
2006; Medina et al. 2014). Molecules controlling the WNK-SPAK/OSR1 cascade, which
phosphorylates KCC2 to increase its functional efficacy, are found to be abnormal in the
PFC of post-mortem brains of schizophrenia patients (Arion and Lewis 2011).
Nevertheless, mechanisms controlling functional regulation of KCC2, other than its
mRNA and protein levels, have not been studied in the context of cortical development.
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2.3 Cerebral Cortical Development and the Subplate
During early development, the earliest-born generation of cells (12-14 weeks of
gestation in human and E9-10 in rats) from the subventricular zone separates into two
groups. One group migrates outwards to form a thin marginal zone that later becomes
layer I of the adult cerebral cortex (Luskin and Shatz 1985), while the second group
remains situated in deeper areas, eventually becoming a thick subplate layer (Luskin and
Shatz 1985). Subplate cells mature rapidly to form a heterogeneous neuronal population
with complex synaptic connections and lies between the developing cortical plate above
and intermediate/subcortical zone (which consists of migrating neurons, glia and
incoming afferent fibers) below (Allendoerfer and Shatz 1994; Judaš et al. 2013). The
subplate layer is conserved across species but is thickest and more complex in monkeys
and humans, suggesting that they may play an important role in higher intercortical
connectivity and function seen in primates (Kanold and Luhmann 2010). The majority of
subplate neurons are glutamatergic, while a smaller proportion of subplate neurons
express GABA (Kostović et al. 2015; Hadders-Algra 2018). In all animals studied, more
than 95% of subplate neurons degenerate (during 35-38 weeks of gestation in human and
postnatal days 4-7 in rodents), and the remaining cells become the interstitial neurons of
the white matter, distributed just beneath layer VI of the cerebral cortex (Chun and Shatz
1989; Price et al. 1997; Rakic and Zecevic 2000; Robertson et al. 2000; HoerderSuabedissen and Molnár 2015). Subplate neurons have extensive axonal and dendritic
arborization and have functional synaptic connections with other subplate neurons,
incoming thalamocortical afferents, and with neurons of the overlying cortical plate
(Kostovic and Rakic 1990; Kanold 2009).
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The subplate plays several critical roles in early brain development. It has been
implicated in thalamocortical axonal pathfinding, development of the cortical columnar
structure, maturation of cortical inhibition, early oscillatory activity, and has been shown
to be critical in the pattern formation of primary somatosensory and visual cortices
(Kanold and Luhmann 2010). For example, earlier in development, the subplate plays an
essential role in guiding thalamocortical axons to their targets within the cortex and
creating a permissive environment for neuronal migration destined for the cortical layers
above. In later stages of development, the subplate integrates into cortical networks to
orchestrate the development of cortical circuitry (Kanold and Luhmann 2010). The
subplate has been shown to play a pivotal role in generating local synchronous oscillatory
network activity early in development, which acts as a functional framework for the
activity-dependent formation of cortical networks and modules during early development
(Dupont et al. 2006; Sun and Luhmann 2007; Yang et al. 2009). The removal of the
subplate in the neonatal rat somatosensory cortex, for example, eliminated endogenous
and sensory evoked spindle burst activity and prevented the development of the barrel
cortex architecture (Tolner et al. 2012).
Compelling evidence indicates a crucial role for subplate in thalamocortical
axonal pathfinding. Subplate neurons send axons through the developing internal capsule
to synapse with ascending thalamocortical axons as early as E12.5 in rats, providing an
important scaffold for thalamic fibers to ascend (Ghosh et al. 1990; Antón-Bolaños et al.
2018; Alzu’bi et al. 2019). In rodent, thalamocortical axons arrive at the subplate layer at
E15-16, when thalamic-recipient neurons of the cortex have not arrived. Consequently,
thalamocortical axons “wait” at the subplate for 4-5 days before entering the cortical
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plate. Based on the complex molecular and electrophysiological events identified, it has
been proposed that this waiting period allows thalamocortical axons to learn the
topography and properties of target neurons in the cortex (Allendoerfer and Shatz 1994;
Auladell et al. 2000; Judaš et al. 2013; Kostović et al. 2015; Hoerder-Suabedissen and
Molnár 2015; Krsnik et al. 2017; Hadders-Algra 2018; Antón-Bolaños et al. 2018;
Alzu’bi et al. 2019). Studies in the primary somatosensory, auditory, and visual cortices
indicates that subplate neurons themselves send a massive projection to layer IV, the
thalamocortical axonal target layer, with respective thalamic afferents waiting in the
subplate (Friauf and Shatz 1991; Wess et al. 2017). In rodents, thalamocortical fibers start
ascending from the subplate into the overlying developing cortex at birth and continue to
invade the cortex until P5-6, when subplate cells start degenerating (Hoerder-Suabedissen
and Molnár 2015).
Experimental subplate ablations have been achieved by use of excitotoxic
injections targeting the subplate’s glutamatergic cells in ferrets and cats, and by
employing immunotoxins targeting the p75 receptor in rodents. In rodents, subplate
neurons begin expressing p75 neurotrophin receptors at birth (Allendoerfer et al. 1990;
Kanold 2009). Lesioning the subplate after thalamocortical axons entered the primary
visual cortex but before ocular dominance columns were established prevented the
formation of ocular dominance columns (Ghosh and Shatz 1992; Ghosh and Shatz 1993;
Ghosh and Shatz 1994; Kanold et al. 2003). Similarly, ablation of subplate neurons of the
primary somatosensory cortex resulted in abnormal barrel formation (HoerderSuabedissen and Molnár 2015). The above evidence confirms a central role for subplate
neurons in the establishment of correct thalamocortical connections and cortical
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functional domains in the primary sensory cortices. Interestingly, developmental
disconnection of the thalamus from the cerebral cortex, especially the PFC, is a widely
held view underlying human schizophrenia (Lewis 2000; Kupferschmidt and Gordon
2018).

2.4 An Overview of Schizophrenia
Schizophrenia is regarded as one of the most disabling psychiatric disorders with
a lifetime prevalence of 0.7% (Mueser and McGurk 2004; Howes et al. 2015). Symptoms
of schizophrenia are often heterogeneous, manifesting in the early twenties and consists
of three categories: (1) positive symptoms (e.g., delusions, hallucinations); (2) negative
symptoms (e.g., anhedonia, social withdrawal); and (3) cognitive symptoms (e.g.,
impairment in working memory, executive function, processing speed). Positive
symptoms of schizophrenia have been consistently linked to the dopamine system and are
thought to be the result of increased dopamine activity in subcortical areas (Brisch et al.
2014). On the other hand, cognitive symptoms of schizophrenia, which usually determine
the long-term outcome and disability, are believed to be resulting from abnormal PFC
function (Mueser and McGurk 2004; Rosenheck et al. 2006; Bowie and Harvey 2006;
Murphy et al. 2006; Tripathi et al. 2018). While positive symptoms can be managed
effectively with antipsychotic drugs, cognitive symptoms do not respond to current
therapies (Miyamoto et al. 2012; Kim et al. 2013; Ogino et al. 2014; MacKenzie et al.
2018).
The most consistent finding of the brains of schizophrenia patients is an
enlargement of the lateral and third ventricles, and an overall reduction in brain volume
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and thinning of grey matter (Selemon et al. 2002). These characteristics cannot be
explained by illness chronicity, as similar findings have been identified in newly
diagnosed patients and patients’ asymptomatic first degree relatives (Mueser and McGurk
2004). Post-mortem studies have identified that the thinning of the cerebral cortex is due
to loss of dendritic spines, axon terminals and synapses, while the total number of
neurons are not changed (Selemon and Goldman-Rakic 1999).
The etiology of schizophrenia is not clear, but include genetic predisposition and
accompanying developmental abnormalities and environmental insults (Zornberg et al.
2000; Mueser and McGurk 2004; Rapoport et al. 2005). A number of genome-wide
association studies have found over 100 schizophrenia-associated loci, and it is widely
believed that interactions among small abnormalities occurring in a large number of
genetic loci may provide predisposition to schizophrenia (Schizophrenia Working Group
of the Psychiatric Genomics Consortium 2014). Twin studies show a 50% chance for
manifesting the disease in monozygotic twins, while dizygotic twins and first degree
relatives show about 10% probability (Sullivan et al. 2003; Lichtenstein et al. 2006).
Environmental factors such as prenatal or birth complications have also been linked to an
increased risk for developing schizophrenia. Maternal influenza, malnutrition, diabetes,
smoking, and obstetric complications (such as hypoxia) as well as socio-environmental
factors such as urban upbringing and adolescent stressors have all been found to increase
the risk for developing schizophrenia.
Schizophrenia is a neurodevelopmental disorder of connectivity, for which the
GABA system plays a crucial role (González-Burgos et al. 2005; Luhmann et al. 2018).
Coordinated firing of dorsolateral prefrontal pyramidal neurons and their interactions
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with PV interneurons are critical for generating gamma oscillations and are essential for
appropriate behavioral responses in cognitive function, such as working memory
(Vierling-Claassen et al. 2008; Cardin et al. 2009; Sohal et al. 2009; Williams and Boksa
2010). Fittingly, gamma oscillations and working memory are impaired in schizophrenia
(Vierling-Claassen et al. 2008; Haenschel et al. 2009; Barr et al. 2010; Uhlhaas and
Singer 2010). It has been suggested that the abnormal gamma oscillations and E/I
imbalance seen in the PFC of schizophrenia patients underlie several cognitive symptoms
of schizophrenia, particularly reflected in the reduced inhibition of cortical pyramidal
neurons (Lewis et al. 2012; Schmidt and Mirnics 2015). The schizophrenia brain has
shown several GABA system-related abnormalities through post-mortem studies. The
most consistent finding is a decrease in PV mRNA and protein levels in layers III and IV
of the dorsolateral PFC. However, no changes in overall number of PV neurons were
detected (Hashimoto et al. 2003; Glausier et al. 2014). Studies have consistently found
decreased GAD67, a protein responsible for the biosynthesis of GABA, mRNA and
protein levels in the dorsolateral PFC of schizophrenia in ~50% of PV neurons in layers
III and IV (Hashimoto et al. 2003; Curley et al. 2011; Rocco et al. 2016).
Genetic manipulation of the GAD67 gene in mice resulted in substantial deficits
in GABAergic transmission from PV interneurons to pyramidal neurons in the PFC,
suggesting that this deficiency of GAD67 in PV neurons contributes to E/I imbalance and
cortical dysfunction seen in schizophrenia (Lazarus et al. 2015). GABA transporter
protein GAT1 levels were also found to be decreased in a subset of GABAergic neurons
in the dorsolateral PFC of schizophrenia patients (Woo et al. 1998; Volk et al. 2001).
Post-mortem studies have also found changes in GABAA receptor subunit composition.
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The GABAA a2 subunit is found predominantly in immature neurons compared to mature
neurons, while the GABAA a1 subunit is found predominantly in more developed, mature
neurons (Sánchez Fernández and Loddenkemper 2014). Interestingly, studies of GABAA
a subunit composition in schizophrenia found increased postsynaptic GABAA a2 subunit
mRNA (immature) and decreased GABAA a1 subunit mRNA (mature) in the dorsolateral
prefrontal cortex (Volk et al. 2002; Takanori Hashimoto et al. 2008; T Hashimoto et al.
2008; Beneyto et al. 2011). A decrease KCC2 protein expression level was also found in
the dorsolateral PFC of schizophrenia (Sullivan et al. 2015). Taken together, it is clear
from established findings and current literature that GABA abnormalities are implicated
in schizophrenia, particularly in cognitive dysfunction, and warrants for further
investigation, perhaps by modeling schizophrenia centred on GABA abnormalities.

2.5 The Subplate and Modeling Schizophrenia
Subplate abnormalities has previously been proposed as part of the
neurodevelopmental hypothesis of schizophrenia (Bunney and Bunney 2000; Kostović et
al. 2011; Luhmann et al. 2018). Although the role of the subplate and the effects of a
pathological subplate have been studied in sensory cortices, it has yet to be determined in
association cortices such as the PFC, which plays a significant role in the manifestation
of cognitive symptoms of schizophrenia. However, several findings implicate the
subplate as having a potential role in schizophrenia during early development. For
example, post-mortem studies of schizophrenia has consistently described abnormal
number or distribution of surviving remnants of subplate neurons in subcortical areas, the
interstitial neurons of the white matter, in the dorsolateral PFC and the temporal cortex
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(Kirkpatrick et al. 1999; Kirkpatrick et al. 2003; Eastwood and Harrison 2003; Eastwood
and Harrison 2005; McQuillen and Ferriero 2005; Kostović et al. 2011; Yang et al.
2011). It has been suggested that this abnormality may be due to, in part, (1)
overproduction of subplate neurons in the beginning of neurogenesis; (2) reduced
apoptosis of subplate neurons; or (3) aberrant migration of subplate neurons (Eastwood
and Harrison 2003; Stolp et al. 2012; Hutsler and Casanova 2016; Luhmann et al. 2018;
Serati et al. 2019). Regardless of the mechanism, these investigators warranted for further
studies into the role of the subplate in schizophrenia yet indicated that the subplate is a
transient structure and in humans, it almost completely degenerates by birth.
Subplate neurons have been found to be particularly susceptible to hypoxicischemic damage at late 3rd trimester (human) and at birth (rodents). Correspondingly,
hypoxic-ischemic damage is the etiological factor that most frequently results in subplate
zone damage, and studies have also consistently found an increased risk for developing
schizophrenia following fetal hypoxia and prematurity as well as obstetric complications
(Kostović et al. 1989; Zornberg et al. 2000; Mueser and McGurk 2004; Rapoport et al.
2005; Volpe 2009; Mathur and Inder 2009; Ferriero and Miller 2010; Nguyen and
McQuillen 2010). It has also been noted in humans that the peak of subplate neuron
development coincides with the gestational ages of highest vulnerability to perinatal brain
injury (McQuillen and Ferriero 2005). Further, preterm infants with periventricular
leukomalacia, which is thought to be caused by hypoxic-ischemic insult, showed
neuronal cell loss and activated microglia in the subplate, further indicating the subplate’s
vulnerability to hypoxic-ischemic damage (Kinney et al. 2012; Pogledic et al. 2014). In
animal studies, fetal hypoxia-ischemia caused a reduction in spindle burst activity,
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abnormal dendrite and spine formation in neocortical pyramidal neurons, and delayed
glutamate receptor expression (Ranasinghe et al. 2015). It has also been proposed that the
ventricular enlargement consistently seen in early stages of schizophrenia may be a
residual sign of hypoxic-ischemic damage to the subplate (Kostović et al. 2011).
Although a wealth of information on structural, functional and electrophysiological
properties of subplate neurons have been revealed in animals, as mentioned above, all are
in sensory cortices, and are not directly relevant to schizophrenia pathogenesis.
Our laboratory has demonstrated that neonatal ablations of the subplate in the
developing PFC resulted in a number of structural and molecular abnormalities relevant
to human schizophrenia, such as enlarged lateral and third ventricles, reduced grey matter
thickness in the PFC, reduced PV protein levels in the PFC (but normal densities of PV
neurons), reduced dendritic spine density in layer II/III pyramidal neurons, and reduced
GAT-1 immunoreactivity restricted to layers II and III (Rajakumar et al. 2004; Desai et
al. 2018). In addition, neonatally subplate ablated animals showed abnormalities in a
number of behavioral tests relevant to human schizophrenia. Interestingly, behavioral
abnormalities were detected only after 9 weeks of age, indicating similarities to delayed
onset of symptoms of schizophrenia. Lesioned animals showed abnormal pre-pulse
inhibition of acoustic startle, abnormalities in stress responsiveness, set-shifting and
reversal learning tests, as well as deficits in social interaction (Rajakumar et al. 2004;
Lazar et al. 2008; Desai et al. 2018). Recapitulation of PFC GABA abnormalities and
cognitive deficits of schizophrenia seen in this animal model following neonatal ablation
of the subplate further substantiate the link amongst the PFC, GABAergic neuronal
development, the subplate, and cognitive symptoms of schizophrenia.
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2.6 Summary
With studies showing the significant role of the subplate in thalamocortical
pathfinding, migration and maturation of cortical GABA neurons and in the formation of
cortical functional domains, which are supported by ablation of the subplate in primary
sensory cortices, it is convincing that the subplate plays a critical role in proper
disposition, wiring, priming and function of the cerebral cortex, and that perhaps much of
these effects are orchestrated via facilitating the normal development of the GABA
system. Associations between abnormalities in GABA development, function in the PFC,
and cognitive deficits of schizophrenia is overwhelming. Perhaps, it is timely to
investigate whether the subplate of the PFC, a multimodal association cortex, would
function similar to that has been described in primary sensory cortices in guiding the
development and maturation of the GABA system.

2.7 Hypothesis and Objectives
Based on the literature, it was hypothesized that neonatal ablation of the subplate
layer of the developing PFC will result in altered developmental patterns of KCC2 and
NKCC1 protein levels and abnormalities in GABA interneurons of the PFC as indicated
above.
Following objectives were studied:
1) To determine the layer-specific expression of KCC2 and NKCC1 proteins in the
prelimbic area (PL) of the PFC at different ages [postnatal day (P) 5, P8, P11, and
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P90] in rats that received neonatal ablations of the subplate of the developing PFC
or sham-infusion.
2) To determine the layer-specific pattern of distribution of GAD67 and parvalbumin
immunolabeled neurons and fibers in the prelimbic area in P23 animals that
received neonatal ablations of the prefrontal cortical subplate or sham procedure.
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Chapter 3

3

Methods

3.1 Animal Model
Timed pregnant females (Sprague-Dawley rats) were obtained from Charles River
Laboratories (St. Constant, QC, Canada) and housed at Western University in the Animal
Care and Veterinary Services building. The facility provided a constant room temperature
and humidity with a 12-hour light/dark cycle and provided environmental enrichment and
food and water ad libitum. Sprague-Dawley rat pups from each litter were randomly
assigned to receive one of two different injections on postnatal days (P) 1 and 2 (day of
birth was considered day 0). On P1 and P2, rat pups were briefly separated from their
mother (4-5 pups at a time and they were separated not more than 5 min from their
mother). One group was infused into the developing prefrontal cortex (0.5 mm anterior to
bregma and 0.5 mm lateral to the midline) with human recombinant nerve growth factor
(NGF; 0.8 µL per side, 125 ng/µL; Cidarlane Laboratories) bilaterally using a custom
made 30 G needle (1 mm deep to the scalp). The injection procedure was repeated again
on day 2. Typically, one-half of animals in a litter received NGF injections and the
reminder was designated as control animals and received 0.8 µL of 0.9% sterile saline
(Hospira Healthcare Inc, Montreal QC, Canada). Pups that received NGF infusions
received a nick on the left ear lobe, while pups that received saline infusions received a
nick on the right ear lobe. Immediately after injections, pups were returned to the mother
and raised under standard conditions. The pups were weaned at 21 days and kept 4
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animals per cage for the remainder of the study. All procedures were approved by the
Canadian Council on Animal Care and were in compliance with the Canadian and
National Institutes of Health Guides for Care and Use of Laboratory Animals.
Previous studies from our laboratory have identified that infusions of NGF cause
apoptosis of subplate neurons (Desai et al. 2018). As reviewed above, subplate neurons
express p75 neurotrophin receptors during postnatal week 1, while immunoreactivity of
p75 is very low in cortical plate neurons. Moreover, trkA receptors are not detected
anywhere in the developing cortex during this period. Therefore, it was hypothesized that
infusions of NGF may induce an apoptotic cascade via p75 receptors in subplate neurons
because of the absence of detectable trkA receptors. As predicted, infusions of NGF
resulted in apoptosis of approximately 25% of subplate neurons at the infusion site at 6-8
hours of infusion without affecting cortical plate neurons (Desai et al. 2018). It was also
determined that the spread of 0.8 µL infusion into the developing medial PFC at P1/P2
involved the entire medial PFC including PL, infra limbic and cingulate areas.
Subsequent dose-response studies have identified that 125 – 250 ng/µL of NGF given
bilaterally on P1 and repeated on P2 produced consistent results in >95% of animals that
received neonatal infusions, showing expected patterns of structural, molecular and
behavioral abnormalities (personal communications to Dr. Rajakumar). Consequently,
several studies have adopted infusing 0.8 µL of 125 ng/µL freshly diluted NGF (from
aliquots kept at -20oC), into the medial PFC at P1 and in P2 rat pups as a method to ablate
the subplate of the PFC.
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3.2 Animal Selection
During the course of this study, several litters of rats were infused with NGF
(50% of the litter) or saline (other 50% of the litter) for on-going parallel studies in the
laboratory (Figure 6). For this study, pairs of NGF or saline infused pups were randomly
selected from different litters. This method of selecting subjects were adopted to prevent
litter effects of possible genetic “homogeneity” and to avoid technical differences across
samples from leaving fixed pup brains in cryoprotective solutions for different periods of
time. In pilot studies, it was evident that neonatal brains cut at 20 µm in the cryostat
provided optimally consistent sections and immunostaining. Furthermore, section
qualities of neonatal brains were heavily affected by fixation and length of post-fixation.

3.3 Tissue Preparation
NGF-infused and saline-infused rats were sacrificed on P5, 8, 11, 23, and 90
(Table 1). On the day of sacrifice, NGF-lesioned and control rats were injected with a
high dose of 50% urethane (0.3 mL; i.p.). When the animals no longer reacted to pain
stimulation, the chest cavity was rapidly opened, and the heart was isolated. A 23 G
injection needle with a stopper allowing only 1 mm at the tip to penetrate was inserted
into the left ventricle. This needle was connected to a 10 mL syringe via a Teflon tubing.
An incision was made into the right atrium to allow the blood and perfusate to escape. P5,
P8, and P11 animals were first perfused with 10 mL of 0.9% saline solution over 2 min
followed by 10 mL of 4% freshly depolymerized formaldehyde in 0.05M phosphate
buffer (PB, pH 7.4), while P23 and P90 animals were perfused with larger volumes.
Following fixation, the entire brain was removed and placed in a 20% buffered sucrose
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solution and left overnight at 4°C, then transferred to 30% sucrose in PB and kept at 4°C
until sectioned.
Brains were cut within 3-4 days into 0.8 mm blocks through the prefrontal cortex
and 20 µm coronal sections were cut using a cryostat. Sections were thaw-mounted on a
glass slide and kept at room temperature overnight, then kept at -20°C in dehumidified
containers until immunohistochemistry was conducted.

3.4 Immunohistochemistry
Sections through the medial PFC from NGF-lesioned animals and saline-infused
animals were processed for KCC2, NKCC1, PV, and GAD67 (see Table 2 for antibodies
used and their respective dilutions). All sections per time point, per antibody were run
concurrently to minimize batch effect. Primary antibody omission controls were run in
parallel at endpoints with highest expression levels (Figure 1). The PV and GAD67
antibodies were used previously in other studies in our laboratory and their affinity to
respective proteins were verified by detecting single bands at predicted size (Rajakumar
et al. 1994).
Slides containing sections were washed in 0.1M PB (4 times for 5 minutes each).
Following the wash, sections were overlayed with blocking solution containing 10%
NGS (normal goat serum, Sigma Canada), 15% BSA (bovine serum albumin, Sigma
Canada), and 0.01% Triton X-100 (Sigma Canada), diluted in 0.1M PB. Sections were
then washed in 0.1M PB solution (4 times for 5 minutes each) before being incubated in
the primary antibody solution, which contained 1% NGS and 0.001% Triton X-100

27

diluted in 0.1M PB. Sections were incubated at room temperature for 18 hours. Sections
were removed from the primary antibody solution and were washed with 0.1M PB (4
times for 5 minutes each). Sections were then incubated in secondary antibody solution
(biotin-conjugated goat-anti mouse or biotin-conjugated goat-anti rabbit) for 1 hour at
room temperature, then washed with 0.1M PB (4 times for 5 minutes each). While
sections were undergoing the wash, avidin-biotin complex (ABC) was made in PB and
incubated at room temperature for 20 minutes. Sections were then overlayed with preincubated ABC in PB for one hour. Sections were washed in 0.1M PB (4 times for 5
minutes each), then incubated in biotinylated tyramide in PB containing 0.003%
hydrogen peroxide for ten minutes. The solution was washed off with 0.1M PB (4 times
for 5 minutes each) and incubated with fluorophore-conjugated avidin or streptavidin
diluted in PB for one hour, then washed with 0.1M PB (4 times for 5 minutes each).
Slides were let dry at room temperature for 1 hour then covered with Vectashield (Vector
Laboratories), and examined promptly using a Zeiss Axiophot microscope (Zeiss, North
York, ON, CA). Selected images were captured using identical exposure and imaging
parameters.

3.5 Data Analysis
Images were analyzed using Image J v.2 software to determine cell count and
fluorescence intensity as CTCF (corrected total cell fluorescence). Layer specific analysis
was conducted by dividing the entire prelimbic cortical area into three bins vertically of
identical size. The first and last bins were used for analysis and assigned as upper
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prelimbic and lower prelimbic layers. The following settings for analyses on Image J v.2
were kept consistent for all images analyzed.
RGB fluorescence images were first converted into 16-bit grayscale (Figure 2).
Background was then subtracted with a rolling ball radius of 20 pixels. As the plugin
subtracts the background value for every pixel around each object, the rolling ball radius
was set as the diameter of the largest object (cell body) in the image that was not
background (Figure 3). A threshold value was determined by applying the Auto
Threshold plugin to the brightest image in the set, which omits extreme values from
analysis (i.e. sets an appropriate range between pixel values 0 and 255 in the image by
omitting extreme values). This threshold was then applied to the subtracted image with
pixel values above the threshold set to white (dark background) (Figure 4). Additional
background noise was subtracted with the Despeckle process, which replaces each pixel
with the median value in its 3x3 neighborhood. The thresholded image was then
redirected to the subtracted image (image from one step prior) and particles were
analyzed for area, minimum and maximum gray value, mean gray value, area fraction,
and integrated density, with values limited to threshold. CTCF values were calculated
according to the formula CTCF = Integrated Density – (Average Area × Mean gray of
background readings) (Potapova et al. 2011; Park et al. 2019; Ibragimova et al. 2020).
Background readings were determined by free-hand selection of background or nucleus.
At least five different background readings from varying areas of the image were
recorded and averaged to subtract from the total integrated density. The CTCF of
prelimbic areas were normalized to CTCF of the primary motor cortex (M1), which is
unaffected by the subplate lesion into the prefrontal cortex, of the same section to control
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for technical variability between sections (Figure 5). An independent t-test was conducted
for the primary motor cortex (See Appendix) and a two-way ANOVA, followed by
Tukey’s post-hoc analyses, were conducted for prelimbic cortical areas using SPSS v.27.
Alpha was set at 0.05. Data are presented as mean + standard error of mean.
Table 1. Animal endpoints used for each study
Animal endpoints used for each study

Endpoint

KCC2

NKCC1

Parvalbumin

GAD67

P5

P5

P23

P23

P8

P8

P11

P11

P90

P90

Note. A total of n=5 animals were sacrificed per end point, per study, with four sections
per animal processed for immunohistochemistry.
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Table 2. Antibody (primary, secondary, and other reagents) used, host species and supplier
Antibody (primary, secondary, and other reagents) used, host species and supplier
Antibody

Dilution

Species

Supplier

Primary Antibodies
KCC2

1:1000

Rabbit polyclonal

Millipore #07-432

NKCC1

1:500

Mouse polyclonal

T4 Developmental
Studies Hybridoma
Bank

Parvalbumin

1:1000

Mouse monoclonal

Millipore #P3088

GAD67

1:500

Mouse polyclonal

Millipore #MAB5406

Secondary Antibodies
Biotin-conjugated goat-

1:500

Goat polyclonal

anti mouse
Biotin-conjugated goat-

#BA-9200
1:500

Goat polyclonal

anti rabbit
Alexa Fluor 488 Goat
anti-mouse (used for
parvalbumin)

Vector Laboratories,

Vector Laboratories,
#BA-1000

1:250

Goat polyclonal

Thermo Fisher #A11029
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Biotinylated Substrates
Avidin-Biotin Complex

1:500

N/A

(Peroxidase)
Biotinylated tyramide

Vector Laboratories
#PK-6100

1:1000

N/A

PerkinElmer Inc,
#NEL700A001KT

Fluorescein Avidin

1:300

N/A

Vector Laboratories,
#A-2001

Streptavidin

1:1000

N/A

Jackson Immuno
Research Labs, #016580-084
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Figure 1: Omission of primary antibody controls
KCC2a

NKCC1b

Parvalbuminc

GAD67c

PL

M1

Figure 1. Omission of primary antibody controls. Primary omission controls were
conducted on the age groups investigated in the current study for which expression levels
were expected to be highest according to existing literature. aKCC2 primary omission
conducted on P90. bNKCC1 primary omission conducted on P5. cParvalbumin and
GAD67 primary omission conducted on P23. Immunohistochemistry protocol for
primary omission controls were identical to protocol above, with the exception of
primary antibody incubation. Images are taken at 20X objective, scale bar 100 µm. PL,
prelimbic cortex; M1, primary motor cortex.
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Figure 2: Conversion of RGB Fluorescence Image into 16-bit grayscale on Image J

Figure 2. Conversion of an RGB fluorescence image into a 16-bit grayscale on Image J
v.2. RGB fluorescence image at 10X of KCC2 in the prelimbic cortex at P5 (left) is
converted into 16-bit grayscale (right).
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Figure 3: Subtracting Background on Image J

A

B

Figure 3. Subtracting background of 16-bit image with rolling ball algorithm on Image J
v.2. (A) The straight line tool was used on the magnified image to measure the diameter
of the biggest object in the image. (B) The diameter (19.99) was used to determine the
rolling ball size for background subtraction. White box indicates the area of magnified
image on the left (A).
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Figure 4: Thresholding Image with Image J

Figure 4. Fluorescence signal in an image with applied threshold and RGB image on
Image J v.2. The threshold value, determined by application of the Auto Threshold
plugin, was applied to the subtracted 16-bit image. The resulting thresholded image (left)
highlights in white the same signal seen in the unaltered RGB fluorescence image in red
(right).

36

Figure 5: Technique Variability is Minimal Within Sections

M1
M1

PL
PL

Figure 5. Technique variability is minimal within sections. Immunolabelling for NKCC1
at 2X in the prefrontal cortex at P5. Note the comparable overall fluorescence in the
NGF-affected PL (left box) and unaffected M1 (right box) areas. PL, prelimbic cortex;
M1, primary motor cortex. Scale bar, 1000 µm.
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Chapter 4

4

Results

4.1 Validation of Successful Neonatal Subplate Ablation
The subplate is a transient layer in the developing cerebral cortex, and subplate
cells almost completely degenerate by the end of the first postnatal week in rats. The
current study used NGF to ablate the subplate, a method employed by several previous
and on-going studies form our laboratory. This method consistently results in apoptosis
of ~25% of subplate cells which appears to be sufficient to provide reproducible
structural, molecular and behavioral abnormalities (Lazar et al. 2008; Cantrup et al. 2012;
Desai et al. 2018). However, because of the transient nature of the subplate cell
population and the highly plastic environment of the neonatal cortex, the lesion procedure
does not leave any residual direct structural evidence. In the current study, cohorts of
animals used were randomly selected from several litters of pups. Remaining animals
were used in parallel on-going studies in our laboratory. Lesioned animals from the same
litters from which my cohorts were randomly selected showed several independent
features consistently seen in adult animals following successful lesioning of the
prefrontal subplate.
Lesioned and control rats, randomly selected from the same litter of pups used in
the current study, were processed for immunohistochemistry or NADPH-diaphorase
histochemistry in parallel studies in our laboratory (Figure 6). All pups used in these
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parallel studies and current study were lesioned or sham-infused identically. Every
animal processed for histology from these series of litters demonstrated expected
features, hence validate a consistency in the successful lesioning in the method adopted.
Similar features have previously been documented in publications from our laboratory
(Lazar et al. 2008; Desai et al. 2018; MacNeil et al. 2020).
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Figure 6: HRP/DAB Detection of Calbindin, NADPH-diaphorase Histochemistry,
and Immunofluorescence for Synaptophysin Show Prefrontal Subplate AblationMediated Structural Changes in the Adult Brain
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Figure 6. Neonatal prefrontal subplate ablation mediated structural changes in the adult
brain. (A, D) Coronal sections through the midlevel of the striatum of 6-month-old
neonatally saline infused (A) or NGF infused (D) rats immunolabelled for calbindin with
HRP/DAB detection. Arrows point to the lateral ventricles. Note that the lateral ventricles
are larger in NGF infused rats. Enlarged lateral and third ventricles are a consistent
finding in successful neonatal ablation of subplate in this model (Lazar et al. 2008). (B,
E) Coronal sections through the PL of 3-month-old rats that received neonatal infusions
of saline (B) or NGF (E) were processed for NADPH-diaphorase histochemistry. Arrows
indicate the borders between the white matter and the lower layer of the grey matter.
Dotted yellow lines mark the extent of grey matter in B and E. Red dotted lines are
placed to show the thinning of grey matter in NGF infused rats. An 18% loss of grey
matter in the PL is a consistent finding in adult animals that received successful neonatal
lesions (Desai et al. 2018). (C, F) Images of synaptophysin labeled PL areas in 3-monthold rats that received neonatal infusions of saline (C) or NGF (F). Note a marked loss of
synapses (arrow) in NGF animals, a consistent finding in successful subplate ablations
(MacNeil et al. 2020). Scale bar, (A, D) 1000 µm, (B, E) 100 µm, (C, F) 20 µm.
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4.2 Parvalbumin Labeling in the Prelimbic Cortex at P23
Post-mortem studies of schizophrenia have shown reduced PV mRNA and protein
levels in layers III and IV of the dorsolateral PFC without any changes in the number of
PV-positive neurons (Hashimoto et al. 2003; Glausier et al. 2014). Similarly, reduced PV
protein levels were identified in tissue punches taken from the entire thickness of the PL
area of the PFC in neonatally lesioned adult rats without changes in the total number of
PV immunoreactive neurons (Desai et al. 2018). However, it is not clear whether changes
in PV levels reported in human patients and in our model are an adult phenomenon
resulting from manifestation of the disease/abnormal behaviour (e.g., as a result of
repeated experience of increased stress response; see Cantrup et al. 2012) or is a
compensatory effect or sequel to abnormalities in the development and maturation of the
GABA system, which may precede manifestation of symptoms. In this study, PV
immunoreactivity patterning was investigated in lesioned animals at P23, immediately
after weaning (weaned at P22). Since human studies have reported a layer-specific PV
decrease in schizophrenia, I sought to examine upper and lower layers of the PL area
separately.
Series of slide-mounted coronal sections through the PL area from P23 animals
that received neonatal infusions of NGF or saline were immunolabelled for PV protein
(Figure 7). Each section through the PL area also contained the primary motor cortex
(M1). Our infusions of NGF was done into the developing medial PFC that is
considerably away from the developing M1 area, therefore, it is unlikely that the lesion
procedure affected the subplate associated with the primary motor cortex. Although a
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secondary effect on GABA neurons of the motor cortex may occur through intracortical
connections and as a result of altered behavior, it is unlikely at this age. Consequently, in
every section analyzed, labeling in M1 was used as a control for technical variations
(Figure 5, also see Appendices). The PL area was arbitrarily divided into upper prelimbic
cortex (UPL; layers II and III), lower prelimbic cortex (LPL; layers V and VI), and the
entire total thickness of the PL area (PL).
A two-way ANOVA was conducted to assess differences in PV expression in the
UPL, LPL and total PL (See Appendix A). Results indicated that mean PV intensity in
the total PL area was significantly lower in NGF (M=1.101, SEM=0.142) compared to
saline (M=1.732, SEM=0.142), [F(1,16)=9.871, p=0.006] animals, but there was no
significant interaction between the effects of lesion and layer-specific PV expression
(p=0.905) (Figure 8). I then asked whether the total number of PV-labeled neurons were
different between NGF-lesion and control groups. A two-way ANOVA was conducted to
assess differences in PV-labeled cell count in the UPL and LPL between groups (See
Appendix A). There were no significant differences between groups (p=0.074) or
interaction between the effects of lesion and layer-specific PV cell counts (p=0.442). To
assess differences across the total PL, an independent t-test was conducted (See
Appendix A). There were no significant differences between groups (p=0.214) of PV cell
count in the total PL cortex (Figure 9), which is consistent with literature on post-mortem
schizophrenia and previous results in adult animals with neonatal lesions.
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Figure 7: Immunofluorescence of Parvalbumin in the Prelimbic Cortex at P23
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Figure 7. Parvalbumin (PV) expression in P23 prelimbic (A-D) and motor (E-H) cortex
in saline-infused and subplate-lesioned (NGF) rats. (A, B) Fluorescence images of
parvalbumin in the prelimbic (PL) cortex of saline animals taken at 10X (A) and 20X
objective (B). (C, D) Fluorescence images of PV in the prelimbic cortex of NGFinfused animals taken at 10X (C) and 20X (D). Note the decrease in fluorescence
intensity per PV-positive cell body (arrow) compared to saline. (E, F) PV expression in
the primary motor cortex of saline animals at 10X objective (E) and 20X (F). (G, H) PV
expression in the primary motor cortex of NGF-infused animals at 10X (E) and 20X (F).
Note the comparable fluorescence intensity per PV-positive cell (arrowhead) between
groups in the primary motor cortex. (I) Primary PV antibody omission control of a P23
saline animal in the PL cortex at 20X. (J) Primary PV antibody omission control of P23
saline animal in the motor cortex at 20X. All imaging parameters were kept consistent.
Scale bar, 100 µm.
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Figure 8: Parvalbumin Fluorescence Intensity in the Prelimbic Cortex at P23
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Figure 8. Parvalbumin (PV) fluorescence intensity in P23 NGF and control (SAL)
comparison in the prelimbic and primary motor cortices. Bars indicate mean values for a
group + SEM, points indicate individual animal data (n=5; 4 sections per animal). (A,
A’) Representative PV fluorescence images of P23 saline (A) and NGF (A’) in the
prelimbic cortex used for analysis, taken at 10X. Higher power inserts on top left. Scale
bar, 100 µm. All imaging parameters were kept consistent. (B) Mean parvalbumin
fluorescence intensity (not normalized) in the upper prelimbic (UPL), lower prelimbic
(LPL), and total prelimbic (PL) cortices. (C) PV fluorescence intensity in the prelimbic
cortex at P23 normalized to primary motor cortex (M1) PV intensity. Mean PV intensity
normalized to M1 was significantly lower in NGF (M=1.01, SEM=0.141) compared to
SAL (M=1.732, SEM=0.142), F (1,16) =9.871, p=0.006 (asterisk), but fluorescence
intensity for UPL and LPL did not differ. (D) Mean PV intensity in the primary motor
cortex. Mean parvalbumin intensity did not differ between groups (p=0.414) in M1.
UPL, upper prelimbic (L2/3); LPL, lower prelimbic (L5/6); PL, total prelimbic cortex;
M1, primary motor cortex; a.u., arbitrary units.
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Figure 9: Parvalbumin Cell Count in the Prelimbic Cortex at P23
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Figure 9. Parvalbumin-positive cell count in P23 NGF and control (SAL) comparison in
the prelimbic and primary motor cortex. Bars indicate mean values for a group + SEM,
points indicate individual animal data (n=5; 4 sections per animal). (A, A’)
Representative parvalbumin (PV) fluorescence images of P23 saline (A) and NGF (A’)
in the prelimbic cortex used for analysis, taken at 10X. Higher power inserts on top left.
Scale bar, 100 µm. All imaging parameters were kept consistent. (B) Mean PV cell count
(not normalized) in the upper prelimbic (UPL), lower prelimbic (LPL), and total
prelimbic (PL) cortices. (C) P23 PV cell count in the prelimbic cortex normalized to
primary motor cortex (M1). Mean PV count normalized to M1 did not differ between
groups. (D) Mean PV intensity in the primary motor cortex. Mean PV intensity did not
differ between groups (p=0.414) in M1. UPL, upper prelimbic (L2/3); LPL, lower
prelimbic (L5/6); PL, total prelimbic cortex; M1, primary motor cortex; a.u., arbitrary
units.
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4.3 GAD67 Labeling in the Prelimbic Cortex at P23
Post-mortem studies of schizophrenia have consistently found a decrease in GAD67
mRNA and protein levels in the dorsolateral PFC. Again, it is not clear whether this
decrease is secondary to chronicity of the disease or medication effect, or whether it
presents prior to manifestation of symptoms. Consequently, I sought to study the pattern
of GAD67 labeling in the PL area in a layer-specific manner, similar to my PV studies.
Series of slide-mounted coronal sections through the PL area from P23 animals that
received neonatal infusions of NGF, or saline were immunolabelled for GAD67 protein.
Each section through the PL area also contains M1 (Figure 10). A two-way ANOVA was
conducted on prelimbic GAD67 CTCF to assess for differences in GAD67 fluorescence
intensity in the upper layers (UPL), lower layers (LPL), and the total thickness of
prelimbic cortex (PL) between groups (See Appendix B). Analysis did not find
significant differences between groups in GAD67 intensity expressed by interneurons in
the PL cortex (p=0.900) or interaction between the effects of lesioning and layer specific
GAD67 expression (p=0.712) (Figure 11). I then asked whether the number of GAD67positive cells were different between NGF-lesion and control groups. A two-way
ANOVA was conducted on UPL and LPL GAD67 cell counts and an independent t-test
was conducted for the overall PL GAD67 cell count (See Appendix B). There were no
significant differences between groups (p=0.109) or interaction between the effects of a
lesioned prefrontal subplate and layer specific GAD67 cell counts (p=0.805). There were
no significant differences between groups in GAD67 cell count of the overall prelimbic
(p=0.386) cortices (Figure 12).

48

Figure 10: Immunofluorescence of GAD67 in the Prelimbic Cortex at P23
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Figure 10. GAD67 expression in P23 prelimbic (A- D) and motor (E- H) cortex in
saline-infused and subplate-lesioned rats. (A, B) Fluorescence images of GAD67 in the
prelimbic cortex of saline animals taken at 10X objective (A) and 20X (B). (C, D)
Fluorescence images of GAD67 in the prelimbic cortex of NGF-infused animals taken at
10X (C) and 20X (D). Note the comparable fluorescence intensity per GAD67-positive
cell body (arrow) compared to saline prelimbic cortex. (E, F) GAD67 expression in the
primary motor cortex of saline animals at 10X objective (E) and 20X (F). (G, H)
GAD67 expression in the primary motor cortex of NGF-infused animals at 10X (G) and
20X (H). Note the comparable fluorescence intensity per GAD67-positive cell body
(arrowhead) between groups in the primary motor cortex. (I) Primary GAD67 antibody
omission control of a P23 saline animal in the prelimbic cortex at 20X. (J) Primary
antibody omission control of P23 saline animal in the motor cortex at 20X objective. All
imaging parameters were kept consistent. Scale bar, 100 µm.
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Figure 11: GAD67 Fluorescence Intensity in the Prelimbic Cortex at P23
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Figure 11. GAD67 fluorescence intensity in P23 NGF and control (SAL) comparison in
the prelimbic and primary motor cortex. Bars indicate mean values for a group + SEM,
points indicate individual animal data (n=5; 4 sections per animal). (A, A’)
Representative GAD67 fluorescence images of P23 saline (A) and NGF (A’) in the PL
cortex used for analysis, taken at 10X. Higher power inserts on top left. Scale bar, 100
µm. All imaging parameters were kept consistent. (B) Mean GAD67 fluorescence
intensity (not normalized) in the upper prelimbic (UPL), lower prelimbic (LPL), and
total prelimbic (PL) cortices. (C) Mean GAD67 fluorescence intensity in the UPL, LPL,
and PL normalized to M1. Normalized mean GAD67 intensity did not differ between
groups. (D) Mean GAD67 fluorescence intensity in M1. Mean GAD67 intensity did not
differ between groups (p=0.738). UPL, upper prelimbic (L2/3); LPL, lower prelimbic
(L5/6); PL, total prelimbic cortex; M1, primary motor cortex; a.u., arbitrary units
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Figure 12: GAD67 Cell Count in the Prelimbic Cortex at P23
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Figure 12. GAD67-positive cell count in P23 NGF and control (SAL) comparison in the
prelimbic and primary motor cortex. Bars indicate mean values for a group + SEM, points
indicate individual animal data (n=5; 4 sections per animal). (A, A’) Representative
GAD67 fluorescence images of P23 saline (A) and NGF (A’) in the prelimbic cortex used
for analysis, taken at 10X. Higher power inserts on top left. Scale bar, 100 µm. All
imaging parameters were kept consistent. (B) Mean GAD67 cell count in the upper
prelimbic (UPL), lower prelimbic (LPL), and total prelimbic (PL) cortices. (C) P23
GAD67 cell count (not normalized) in the prelimbic cortex normalized to primary motor
cortex (M1). (D) Mean GAD67 intensity in the M1. Mean GAD67 intensity did not differ
between groups (p=0.738) in M1. UPL, upper prelimbic (L2/3); LPL, lower prelimbic
(L5/6); PL, total prelimbic cortex; M1, primary motor cortex; a.u., arbitrary units
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4.4 Pattern of KCC2 Immunoreactivity During Development
in the Prelimbic Cortex
Evidence indicates that ablation of the subplate in the developing primary visual
cortex results in delayed upregulation of KCC2 mRNA in thalamocortical recipient layer
IV (Kanold and Shatz 2006). This delay in KCC2 upregulation was associated with a
continued presence of GABA-mediated depolarization, affecting the E/I balance of the
visual cortex. Interestingly, a decrease in KCC2 protein levels in the dorsolateral PFC in
schizophrenia patients have also been reported (Sullivan et al. 2015). Thus, the primary
goal of the current study was to determine whether a subplate lesion in the developing
PFC would affect the developmental changes in the pattern of KCC2 protein levels in the
PFC. KCC2, which appears perinatally, peaks in expression levels between postnatal
weeks 2 and 3 in rodent, reflecting expression levels seen in adult (Gerald H. Clayton et
al. 1998; Wang et al. 2002; Stein et al. 2004; Dzhala et al. 2005; Kovács et al. 2014). I
therefore sought to investigate KCC2 expression levels throughout development in
animals at P5, P8, P11, and P90, which received neonatal infusions of NGF or saline.
Coronal sections from NGF and saline animals were processed for
immunohistochemistry for KCC2 protein in the PL and M1 in the same sections. Each
time point had 5 animals, and 4 sections from each animal were processed.
At P5, immunolabeling of KCC2 in the PL of both NGF and saline animals were
mostly seen as punctate dots. Of these, several cell membranes were labelled distinctly
(Figure 13). In contrast, cell bodies of the M1 area of both NGF and saline animals were
more intensely labelled compared to the PL cortex in both their membranes and punctate
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signal surrounding cell bodies (Figure 14). Qualitatively, findings of both NGF and saline
animals were consistent with previous studies of KCC2 protein localization in rodent
early during the first postnatal week (Kovács et al. 2014). To quantify KCC2 expression
and investigate for layer-specific differences between NGF and saline animals, a two-way
ANOVA was conducted on the PL at P5 (See Appendix C). Consistent with qualitative
observation, mean KCC2 CTCF did not differ in the prelimbic cortex across groups
(p=0.193), and there was no significant interaction between a prefrontal subplate lesion
and layer specificity of KCC2 signal (p=0.716) (Figure 15). Thus, KCC2 expression
levels in PL of prefrontal subplate-lesioned animals did not differ significantly from
saline animals at P5.
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Figure 13: Immunofluorescence of KCC2 in the Prelimbic Cortex at P5
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Figure 13. Immunofluorescence images showing the distribution of KCC2 in the
prelimbic cortex of saline and NGF animals at P5. (A- C) Immunolabelling of KCC2 in
the right prelimbic cortex of P5 saline at 10X (A), 20X (B), and enlarged 20X (C). (D- F)
Immunolabelling of KCC2 in the left prelimbic cortex of P5 NGF at 10X (D), 20X (E),
and enlarged 20X (F). At P5, KCC2 is most observed in the prelimbic cortex as punctate
forms around cell bodies (white arrow) and surrounding neuropil (white arrowhead).
KCC2 is found localized in several cell membranes (notched arrow) in both NGF and
saline. Scale bar, 100 µm.
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Figure 14: Immunofluorescence of KCC2 in the Primary Motor Cortex at P5
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Figure 14. Immunofluorescence images showing the distribution of KCC2 in the
primary motor cortex of saline and NGF animals at P5. (A- C) Immunolabelling of
KCC2 in the primary motor cortex of P5 saline at 10X (A), 20X (B), and enlarged 20X
(C). (D- F) Immunolabelling of KCC2 in the primary motor cortex of P5 NGF at 10X
(D), 20X (E), and enlarged 20X (F). At P5, KCC2-labelled puncta surrounding cell
bodies (white arrow) and neuropil (white arrowhead) are larger than in the prelimbic
cortex. KCC2 is found localized more distinctly in cell membranes (notched arrow) in
both NGF and saline in the primary motor cortex than in the prelimbic cortex. Scale bar,
100 µm.
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Figure 15. KCC2 fluorescence intensity in the Prelimbic Cortex at P5
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Figure 15. KCC2 fluorescence intensity in P5 NGF and control (SAL) comparison in the
prelimbic cortex. Bars indicate mean values for a group + SEM, points indicate
individual animal data (n=5; 4 sections per animal). (A- A’’) Representative KCC2
fluorescence image of P5 saline and (B- B’’) P5 NGF in the prelimbic cortex used for
analysis, taken at 10X (A, B), magnified on Image J (A’, B’), and threshold applied to
highlight positive signal in white (A”, B”). Scale bar, 100 µm. All imaging parameters
were kept consistent. (C) Mean P5 KCC2 CTCF (not normalized) in the UPL, LPL, and
total PL. (D) Mean P5 KCC2 CTCF in UPL, LPL, and total PL normalized to M1.
Normalized mean KCC2 CTCF did not differ between groups. (E) Mean P5 KCC2
CTCF in M1. Mean M1 KCC2 CTCF did not differ between groups (p=0.915). UPL,
upper prelimbic (L2/3); LPL, lower prelimbic (L5/6); PL, total prelimbic cortex; M1,
primary motor cortex; a.u., arbitrary units
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In rats, KCC2 expression increases dramatically during the first two postnatal
weeks, and peaks between postnatal weeks 2 and 3, reflecting expression levels seen in
adult (G H Clayton et al. 1998). Accordingly, I investigated KCC2 expression in PL areas
at P8 and P11 in neonatally NGF or saline infused rats to determine whether there was a
delay in upregulation of KCC2 in subplate ablated animals.
At P8, expression of KCC2 in the prelimbic cortex of both NGF and saline were
predominantly found as localized clusters of puncta, many surrounding cell bodies. The
size and intensity of puncta enclosing cell bodies and surrounding neuropil were
noticeably greater at P8 compared to P5. As well, membrane labelling was more
predominant at P8 (Figure 16). In the primary motor cortex, immunolabelling of KCC2
was similar to that of the prelimbic cortex, with signal mainly found in the membranes of
neuronal cell bodies and in surrounding neuropil (Figure 17). In deeper layers of the
motor cortex, KCC2 was expressed in perinuclear regions of several neurons. To quantify
the level of KCC2 fluorescence intensity and investigate for layer-specific differences
between NGF and saline animals, a two-way ANOVA was conducted on the prelimbic
cortex at P8 (See Appendix C). Consistent with qualitative observation, mean KCC2
CTCF did not differ in the PL area across groups (p=0.268) and there were no
interactions between a subplate lesion and layer-specificity in KCC2 expression
(p=0.968) (Figure 18). Thus, at the end of the first postnatal week, NGF and saline
animals did not differ in their expression levels of KCC2 in the PL area as detected by
immunolabelling.
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Figure 16: Immunofluorescence of KCC2 in the Prelimbic Cortex at P8
SAL 10X

SAL 20X

SAL Enlarged

A

B

C

NGF 10X

NGF 20X

NGF Enlarged

D

E

F

Figure 16. Immunofluorescence images showing the distribution of KCC2 in the
prelimbic cortex of saline and NGF animals at P8. (A- C) Immunolabelling of KCC2 in
the right prelimbic cortex of P8 saline at 10X (A), 20X (B), and enlarged 20X (C).
(D- F) Immunolabeling of KCC2 in the left prelimbic cortex of P8 NGF at 10X (D),
20X (E), and enlarged 20X (F). At P8, KCC2 is most observed as punctate clusters
around cell bodies (white arrow) and surrounding neuropil (white arrowhead) in the
prelimbic cortex. Immunolabelling is also present in cell membranes (notched arrow) in
both NGF and saline. Scale bar, 100 µm.
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Figure 17: Immunofluorescence of KCC2 in the Primary Motor Cortex at P8
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Figure 17. Immunofluorescence images showing the distribution of KCC2 in the
primary motor cortex of saline and NGF animals at P8. (A- C) Immunolabelling of
KCC2 in the primary motor cortex of P8 saline at 10X (A), 20X (B), and enlarged 20X
(C). (D- F) Immunolabeling of KCC2 in the primary motor cortex of P8 NGF at 10X
(D), 20X (E), and enlarged 20X (F). At P8, similar to the prelimbic cortex, KCC2 is
observed as punctate clusters around cell bodies (white arrow) and surrounding neuropil
(white arrowhead). Immunolabelling is also present in cell membranes (notched arrow)
in both NGF and saline. Perinuclear KCC2 expression is seen in deeper layers of the
primary motor cortex (empty notched arrow). Scale bar, 100 µm.
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Figure 18: KCC2 fluorescence intensity in the Prelimbic Cortex at P8
SAL 10X
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Figure 18. KCC2 fluorescence intensity in P8 NGF and control (SAL) comparison in the
prelimbic cortex. Bars indicate mean values for a group + SEM, points indicate
individual animal data (n=5; 4 sections per animal). (A- A’’) Representative KCC2
fluorescence image of P8 saline and (B- B’’) P8 NGF in the prelimbic cortex used for
analysis, taken at 10X (A, B), magnified on Image J (A’, B’), and threshold applied to
highlight positive signal in white (A”, B”). Scale bar, 100 µm. All imaging parameters
were kept consistent. (C) Mean P8 KCC2 CTCF (not normalized) in the UPL, LPL, and
total PL. (D) Mean P8 KCC2 CTCF in UPL, LPL, and total PL normalized to M1.
Normalized mean KCC2 CTCF did not differ between groups. (E) Mean P8 KCC2 CTCF
in M1. Mean M1 KCC2 CTCF did not differ between groups (p=.937). UPL, upper
prelimbic (L2/3); LPL, lower prelimbic (L5/6); PL, total prelimbic cortex; M1, primary
motor cortex; a.u., arbitrary units.
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At P11, plasma membrane labelling of KCC2 was more prominent than at earlier
ages, with signal distributed throughout neuropil in the PL area of both NGF and saline
animals (Figure 19), consistent with previous findings (Kovács et al. 2014; Amadeo et al.
2018). In the M1 area, KCC2 immunolabelling was present in the plasma membrane and
surrounding neuropil, but also in perinuclear regions of neurons in the superficial layers
(Figure 20). KCC2 fluorescence signal in the PL area was qualitatively similar in NGF
and saline animals. To quantify KCC2 fluorescence intensity in the PL at P11, a two-way
ANOVA was conducted (See Appendix C). Similar to qualitative findings, mean KCC2
CTCF did not differ in PL across groups (p=0.619) and there was no significant
interaction between the effects of a prefrontal subplate lesion and layer specific KCC2
expression (p=0.316) (Figure 21). Thus, there were no significant differences in KCC2
expression in the PL area between NGF and saline animals during the second postnatal
week.
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Figure 19: Immunofluorescence of KCC2 in the Prelimbic Cortex at P11
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Figure 19. Immunofluorescence images showing the distribution of KCC2 in the
prelimbic cortex of saline and NGF animals at P11. (A- C) Immunolabelling of KCC2
in the left prelimbic cortex of P11 saline at 10X (A), 20X (B), and enlarged 20X (C).
(D- F) Immunolabelling of KCC2 in the left prelimbic cortex of P11 NGF at 10X (D),
20X (E), and enlarged 20X (F). At P11, KCC2 localization in the plasma membrane
(notched arrow) is distinct, with some labelling seen as puncta surrounding cell bodies
(white arrow) and labelling in neuropil (white arrowhead) in both NGF and saline. Scale
bar, 100 µm.
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Figure 20: Immunofluorescence of KCC2 in the Primary Motor Cortex at P11
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Figure 20. Immunofluorescence images showing the distribution of KCC2 in the primary
motor cortex of saline and NGF animals at P11. (A- C) Immunolabelling of KCC2 in the
right primary motor cortex of P11 saline at 10X (A), 20X (B), and enlarged 20X (C). (DF) Immunolabelling of KCC2 in the left primary motor cortex of P11 NGF at 10X (D),
20X (E), and enlarged 20X (F). At P11, KCC2 localization in the plasma membrane
(notched arrow) is distinct, with some labelling seen as puncta surrounding cell bodies
(white arrow) and labelling in neuropil (white arrowhead) in both NGF and saline.
Perinuclear KCC2 expression is seen in superficial layers of the primary motor cortex at
P11 (empty notched arrow). Scale bar, 100 µm.
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Figure 21: KCC2 fluorescence intensity in the Prelimbic Cortex at P11
SAL 10X
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Figure 21. KCC2 fluorescence intensity in P11 NGF and control (SAL) comparison
in the prelimbic cortex. Bars indicate mean values for a group + SEM, points indicate
individual animal data (n=5; 4 sections per animal). (A) Representative KCC2
fluorescence image of P11 saline and (B) P11 NGF in the prelimbic cortex used for
analysis, taken at 10X (A, B), magnified on Image J (A’, B’), and threshold applied to
highlight positive signal in white (A”, B”). Scale bar, 100 µm. All imaging parameters
were kept consistent. (C) Mean P11 KCC2 CTCF (not normalized) in the UPL, LPL,
and total PL. (D) Mean P11 KCC2 CTCF in UPL, LPL, and total PL normalized to
M1. Normalized mean KCC2 CTCF did not differ between groups. (E) Mean P11
KCC2 CTCF in M1. Mean M1 KCC2 CTCF did not differ between groups (p=.192).
UPL, upper prelimbic (L2/3); LPL, lower prelimbic (L5/6); PL, total prelimbic cortex;
M1, primary motor cortex; a.u., arbitrary units.
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Previously, it has been shown in the visual cortex of cats that a neonatal subplate
lesion results in delayed upregulation of KCC2 mRNA in thalamocortical recipient layer
IV as an adult, associated with a prolonged GABAergic depolarization also in adult layer
IV (Kanold and Shatz 2006). Thus, I looked at KCC2 protein expression in the adult
(P90) of PFC of rats that received neonatal subplate lesions. In the adult PL, KCC2
immunolabelling was mostly seen as punctate clusters in the neuropil, with several
plasma membrane labelling (Figure 22). In M1, expression patterns were similar, with a
strongly labelled molecular layer 1 (Figure 23), consistent with the literature (Szabadics
et al. 2006; Kovács et al. 2014; Amadeo et al. 2018). To quantify the fluorescence
intensity in the prelimbic cortex, a two-way ANOVA was conducted (See Appendix C).
The mean KCC2 CTCF did not differ between groups (p=0.490), and there was no
significant interaction between a lesioned subplate and layer-specific expression of KCC2
(p=0.901) (Figure 24). Thus, prelimbic KCC2 expression levels of adult prefrontal
subplate-lesioned animals did not differ significant from saline animals.
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Figure 22: Immunofluorescence of KCC2 in the Prelimbic Cortex at P90
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Figure 22. Immunofluorescence images showing the distribution of KCC2 in the
prelimbic cortex of saline and NGF animals at P90. (A- C) Immunolabelling of KCC2 in
the right prelimbic cortex of P90 saline at 10X (A), 20X (B), and enlarged 20X (C). (DF) Immunolabelling of KCC2 in the left prelimbic cortex of P90 NGF at 10X (D), 20X
(E), and enlarged 20X (F). At P90, KCC2 is most observed as puncta in neuropil (white
arrowhead). KCC2 is found in several plasma membranes (notched arrow) and as
punctate forms enclosing cell bodies (white arrow). (G) Primary KCC2 antibody
omission control of P90 saline prelimbic cortex at 20X. Scale bar, 100 µm.
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Figure 23: Immunofluorescence of KCC2 in the Primary Motor Cortex at P90
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Figure 23. Immunofluorescence images showing the distribution of KCC2 in the primary
motor cortex of saline and NGF animals at P90. (A- C) Immunolabelling of KCC2 in the
primary motor cortex of P90 saline at 10X (A), 20X (B), and enlarged 20X (C). (D- F)
Immunolabelling of KCC2 in the primary motor cortex of P90 NGF at 10X (D), 20X (E),
and enlarged 20X (F). At P90, KCC2 labelling is most prominent as punctate dots on
neuropil (white arrowhead). Several plasma membranes are labelled (notched arrow),
with few perinuclear KCC2 expression (empty notched arrow). (G) Primary KCC2
antibody omission control of P90 saline primary motor cortex at 20X. Scale bar, 100 µm.
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Figure 24: KCC2 Fluorescence Intensity in the Prelimbic Cortex at P90
SAL 10X
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Figure 24. KCC2 fluorescence intensity in P90 NGF and control (SAL) comparison in
the prelimbic cortex. Bars indicate mean values for a group + SEM, points indicate
individual animal data (n=5; 4 sections per animal). (A- A’’) Representative KCC2
fluorescence image of P90 saline and (B- B’’) P90 NGF in the prelimbic cortex used for
analysis, taken at 10X (A, B), magnified on Image J (A’, B’), and threshold applied to
highlight positive signal in white (A”, B”). Scale bar, 100 µm. All imaging parameters
were kept consistent. (C) Mean P90 KCC2 CTCF (not normalized) in the UPL, LPL, and
overall PL. (D) Mean P90 KCC2 CTCF in UPL, LPL, and overall PL normalized to M1.
Normalized mean KCC2 CTCF did not differ between groups. (E) Mean P90 KCC2
CTCF in M1. Mean M1 KCC2 CTCF did not differ between groups (p=0.898). UPL,
upper prelimbic (L2/3); LPL, lower prelimbic (L5/6); PL, total prelimbic cortex; M1,
primary motor cortex; a.u., arbitrary units.
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4.5 Pattern of NKCC1 Immunoreactivity During
Development in the Prelimbic Cortex
NKCC1 works together with KCC2 to determine the intracellular chloride
concentration of the neuron, modulating GABA polarity. At early developmental periods,
higher NKCC1:KCC2 expression levels generate a depolarizing response. With a
developmental upregulation in KCC2, the NKCC1:KCC2 ratio decreases, generating a
hyperpolarizing response (Yamada et al. 2004; Hyde et al. 2011; Moore et al. 2017). A
subplate lesion in the developing visual cortex resulted in a decrease in KCC2 mRNA in
layer IV of the visual cortex, but the authors did not elucidate on NKCC1 levels of the
visual cortex (Kanold and Shatz 2006). Thus, I investigated whether there were layerspecific alterations in the developmental regulation of NKCC1 in parallel with KCC2 in
prefrontal cortex subplate-lesioned rats compared to their control saline counterparts.
During the first postnatal week in rats, NKCC1 protein expression is robust in most
cortical neurons (Dzhala et al. 2005). Levels of NKCC1 continue to increase during the
first two postnatal weeks and are significantly higher in expression during this age
compared to adult, then plateau around the beginning of the third postnatal week and
remain steady into adulthood (G H Clayton et al. 1998; Wang et al. 2002). I thus
investigated NKCC1 expression levels throughout development in animals that received
neonatal lesions of the prefrontal cortical subplate using NGF or saline-infused controls.
P5, P8, P11, and P90 NGF and saline animals were immunolabelled for NKCC1 protein
expression in the prelimbic cortex and primary motor cortex.
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At P5, expression of NKCC1 in the prelimbic cortex of both NGF and saline
animals were predominantly seen in punctate dots, especially in the neuropil, with only
few neurons labelled in their plasma membranes (Figure 25). NKCC1 immunolabelling
in the primary motor cortex was similar, with perinuclear NKCC1 labelling in the
superficial layers (Figure 26). Qualitative findings were consistent with previous findings
(Amadeo et al. 2018). To quantify the layer-specific expression of NKCC1 in the
prelimbic cortex at P5, a two-way ANOVA was conducted (See Appendix D). There
were no significant differences between NGF and saline animals in NKCC1 CTCF in the
overall prelimbic cortex (p=.523), and there was no significant difference in layer specific
NKCC1 CTCF between groups (p=.934) (Figure 27). Consistent with qualitative
findings, there were no significant differences in NKCC1 expression in the prelimbic
cortex between NGF and saline animals early during the first postnatal week.
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Figure 25: Immunofluorescence of NKCC1 in the Prelimbic Cortex at P5
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Figure 25. Immunofluorescence images showing the distribution of NKCC1 in the
prelimbic cortex of saline and NGF animals at P5. (A- C) Immunolabelling of NKCC1 in
the prelimbic cortex of P5 saline at 10X (A), 20X (B), and enlarged 20X (C). (D- F)
Immunolabeling of NKCC1 in the prelimbic cortex of P5 NGF at 10X (D), 20X (E), and
enlarged 20X (F). At P5, NKCC1 is predominantly labelled in neuropil as punctate forms
(white arrowhead), with few neurons labelled in their plasma membranes (notched arrow)
in both NGF and saline. Most cell bodies are surrounded by punctate clusters (white
arrow). (G) Primary NKCC1 antibody omission control of P5 saline in the prelimbic
cortex. Scale bar, 100 µm.
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Figure 26: Immunofluorescence of NKCC1 in the Primary Motor Cortex at P5
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Figure 26. Immunofluorescence images showing the distribution of NKCC1 in the
primary motor cortex of saline and NGF animals at P5. (A- C) Immunolabelling of
NKCC1 in the primary motor cortex of P5 saline at 10X (A), 20X (B), and enlarged 20X
(C). (D- F) Immunolabeling of NKCC1 in the primary motor cortex of P5 NGF at 10X
(D), 20X (E), and enlarged 20X (F). At P5, NKCC1 immunolabelling is most prominent
as punctate forms on neuropil (white arrowhead) and in perinuclear areas of neurons in
the superficial layers (empty notched arrow). Few neurons are distinctly labelled in their
plasma membranes (notched arrow), and several neurons are surrounded by punctate
labelling (white arrow). (G) Primary NKCC1 antibody omission control of P5 saline in
the primary motor cortex at 20X. Scale bar, 100 µm.
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Figure 27: NKCC1 Fluorescence Intensity in the Prelimbic Cortex at P5
SAL 10X
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Figure 27. NKCC1 fluorescence intensity in P5 NGF and control (SAL) comparison in
the prelimbic cortex. Bars indicate mean values for a group + SEM, points indicate
individual animal data (n=5; 4 sections per animal). (A- A’’) Representative NKCC1
fluorescence image of P5 saline and (B- B’’) P5 NGF in the prelimbic cortex used for
analysis, taken at 10X (A, B), magnified on Image J (A’, B’), and threshold applied to
highlight positive signal in white (A”, B”). Scale bar, 100 µm. All imaging parameters
were kept consistent. (C) Mean P5 NKCC1 CTCF (not normalized) in the UPL, LPL, and
total PL. (D) Mean P5 NKCC1 CTCF in UPL, LPL, and total PL normalized to M1.
Normalized mean NKCC1 CTCF did not differ between groups. (E) Mean P5 NKCC1
CTCF in M1. Mean M1 NKCC1 CTCF did not differ between groups (p=0.823). UPL,
upper prelimbic (L2/3); LPL, lower prelimbic (L5/6); PL, total prelimbic cortex; M1,
primary motor cortex; a.u., arbitrary units.
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Next, we examined the layer-specific expression patterns of NKCC1 in the
prelimbic cortex of neonatally NGF or saline infused rats at P8. At P8, NKCC1 signal
intensity in the prelimbic cortex was strongest in plasma membranes in both NGF and
saline groups. Labelling was also seen in neuropil as punctate forms surrounding cell
bodies, with no clear differences among layers (Figure 28). In the primary motor cortex at
P8, similar to the prelimbic cortex, labelling was strongest in plasma membranes, with
moderate labelling of neuropil as punctate forms. Perinuclear expression was also seen in
the primary motor cortex in several cells (Figure 29). A two-way ANOVA was conducted
to assess the layer-specific expression of NKCC1 in the prelimbic cortex of P8 NGF and
saline (See Appendix D). NGF and saline animals did not differ in their overall prelimbic
NKCC1 expression (p=0.155) and did not exhibit layer-specific differences (p=0.607)
(Figure 30). At the end of the first postnatal week, NGF and saline animals did not differ
significantly in NKCC1 expression in the prelimbic cortex as detected by
immunofluorescence.
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Figure 28: Immunofluorescence of NKCC1 in the Prelimbic Cortex at P8
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Figure 28. Immunofluorescence images showing the distribution of NKCC1 in the
prelimbic cortex of saline and NGF animals at P8. (A- C) Immunolabelling of NKCC1 in
the right prelimbic cortex of P8 saline at 10X (A), 20X (B), and enlarged 20X (C). (D- F)
Immunolabeling of NKCC1 in the right prelimbic cortex of P8 NGF at 10X (D), 20X
(E), and enlarged 20X (F). At P8, labelling was predominantly seen in plasma
membranes (notched arrow), with some labelling in surrounding neuropil as punctate
forms (white arrowhead) and perinuclear areas (empty notched arrow). Scale bar, 100
µm.
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Figure 29: Immunofluorescence of NKCC1 in the Primary Motor Cortex at P8
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Figure 29. Immunofluorescence images showing the distribution of NKCC1 in the
primary motor cortex of saline and NGF animals at P8. (A- C) Immunolabelling of
NKCC1 in the primary motor cortex of P8 saline at 10X (A), 20X (B), and enlarged 20X
(C). (D- F) Immunolabeling of NKCC1 in the primary motor cortex of P8 NGF at 10X
(D), 20X (E), and enlarged 20X (F). Labelling is mainly localized to cell plasma
membranes (notched arrow) in both NGF and saline, with perinuclear labelling (empty
notched arrow). Punctate labelling of neuropil (white arrowhead) is less predominant
than in the prelimbic cortex. Scale bar, 100 µm.
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Figure 30: NKCC1 Fluorescence Intensity in the Prelimbic Cortex at P8
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Figure 30. NKCC1 fluorescence intensity in P8 NGF and control (SAL) comparison in
the prelimbic cortex. Bars indicate mean values for a group + SEM, points indicate
individual animal data (n=5; 4 sections per animal). (A- A’’) Representative NKCC1
fluorescence image of P8 saline and (B- B’’) P8 NGF in the prelimbic cortex used for
analysis, taken at 10X (A, B), magnified on Image J (A’, B’), and threshold applied to
highlight positive signal in white (A”, B”). Scale bar 100 µm. All imaging parameters
were kept consistent. (C) Mean P8 NKCC1 CTCF (not normalized) in the UPL, LPL, and
total PL. (D) Mean P8 NKCC1 CTCF in UPL, LPL, and total PL normalized to M1.
Normalized mean NKCC1 CTCF did not differ between groups. (E) Mean P8 NKCC1
CTCF in M1. Mean M1 NKCC1 CTCF did not differ between groups (p=0.063). UPL,
upper prelimbic (L2/3); LPL, lower prelimbic (L5/6); PL, total prelimbic cortex; M1,
primary motor cortex; a.u., arbitrary units.

85

As NKCC1 protein expression is robustly upregulated during the first two
postnatal weeks, I next looked at NKCC1 in the PL cortex of P11 animals that received
neonatal infusions of NGF or saline. In the PL cortex, labelling was strongest around cell
bodies. Signal was present in plasma membranes, as well as in perinuclear regions in
several neurons (Figure 31). There were no clear differences among layers in the PL
cortex between NGF and saline. In the primary motor cortex, plasma membrane labelling
of NKCC1 was more robust, with more neurons strongly labelled with perinuclear
NKCC1 (Figure 32). A two-way ANOVA was conducted on the prelimbic cortex of P11
NGF and saline animals to assess for layer-specific differences in NKCC1 expression
(See Appendix D). Consistent with qualitative findings, there was no significant
difference in NKCC1 expression in the overall prelimbic cortex (p=0.406) or in specific
layers (p=0.785) (Figure 33). Thus, during the second postnatal week, NGF and saline
animals did not differ in their NKCC1 expression levels in the PL cortex as detected by
immunofluorescence.
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Figure 31: Immunofluorescence of NKCC1 in the Prelimbic Cortex at P11
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Figure 31. Immunofluorescence images showing the distribution of NKCC1 in the
prelimbic cortex of saline and NGF animals at P11. (A- C) Immunolabelling of NKCC1
in the left prelimbic cortex of P11 saline at 10X (A), 20X (B), and enlarged 20X (C). (DF) Immunolabeling of NKCC1 in the left prelimbic cortex of P11 NGF at 10X (D), 20X
(E), and enlarged 20X (F). At P11, NKCC1 is predominantly labelled plasma membranes
(notched arrow) in both NGF and saline. Faint perinuclear labelling is also present in
several cells (empty notched arrow). NKCC1 can also be seen expressed in neuropil as
punctate forms (white arrowhead) in both NGF and saline. Scale bar, 100 µm.
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Figure 32: Immunofluorescence of NKCC1 in the Primary Motor Cortex at P11
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Figure 32. Immunofluorescence images showing the distribution of NKCC1 in the
primary motor cortex of saline and NGF animals at P11. (A- C) Immunolabelling of
NKCC1 in the left primary motor cortex of P11 saline at 10X (A), 20X (B), and enlarged
20X (C). (D- F) Immunolabeling of NKCC1 in the right primary motor cortex of P11
NGF at 10X (D), 20X (E), and enlarged 20X (F). At P11, NKCC1 is predominantly
labelled plasma membranes (notched arrow) in both NGF and saline. Strong perinuclear
labelling is also present in neurons (empty notched arrow) throughout layers. NKCC1
can also be seen expressed in neuropil as faint punctate forms (white arrowhead) in both
NGF and saline. Scale bar, 100 µm.
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Figure 33: NKCC1 Fluorescence Intensity in the Prelimbic Cortex at P11
SAL 10X

A

A’

A”

B’

B”

NGF 10X

B
(C)

P11 Prelimbic Cortex NKCC1
Intensity

P11 Prelimbic Cortex NKCC1 Normalized
Intensity

1.8

900

1.6

CTCF Normalized to M1 (a.u.)

1000

800
700

CTCF (a.u.)

(D)

600
500
400
300
200

1.4
1.2
1
0.8
0.6
0.4
0.2

100
0

0
UPL
SAL

NGF

LPL
Animal Data

PL

UPL
SAL

LPL
NGF

//

Animal Data

PL

89

(E) P11 Primary Motor Cortex NKCC1
Intensity
900
800

CTCF (a.u.)

700
600
500
400
300
200
100
0
SAL

NGF

Figure 33. NKCC1 fluorescence intensity in P11 NGF and control (SAL) comparison in
the prelimbic cortex. Bars indicate mean values for a group + SEM, points indicate
individual animal data (n=5; 4 sections per animal). (A- A’’) Representative NKCC1
fluorescence image of P11 saline and (B- B’’) P11 NGF in the prelimbic cortex used for
analysis, taken at 10X (A, B), magnified on Image J (A’, B’), and threshold applied to
highlight positive signal in white (A”, B”). Scale bar 100 µm. All imaging parameters
were kept consistent. (C) Mean P11 NKCC1 CTCF (not normalized) in the UPL, LPL,
and total PL. (D) Mean P11 NKCC1 CTCF in UPL, LPL, and total PL normalized to M1.
Normalized mean NKCC1 CTCF did not differ between groups. (E) Mean P11 NKCC1
CTCF in M1. Mean M1 NKCC1 CTCF did not differ between groups (p=0.927). UPL,
upper prelimbic (L2/3); LPL, lower prelimbic (L5/6); PL, total prelimbic cortex; M1,
primary motor cortex; a.u., arbitrary units.
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Lastly, I investigated NKCC1 expression in the prelimbic cortex of NGF and
saline animals at P90. In adults, NKCC1 expression was faintly present in the apical
dendrites of cortical neurons, mostly in the superficial layers of the PL cortex of rats that
received neonatal infusions of NGF or saline. Plasma membrane labelling was scarce,
while punctate labelling of neuropil was present (Figure 34). On the other hand, in the
primary motor cortex of adults, cytoplasmic and perinuclear labelling was predominant,
with expression seen in scattered apical dendrites (Figure 35). To quantify NKCC1
expression levels in the prelimbic cortex, a two-way ANOVA was conducted (See
Appendix D). There was no significant difference in NKCC1 expression in the overall
prelimbic cortex (p=0.509) or in specific layers (p=0.971) between NGF and saline
animals (Figure 36). Thus, a prefrontal NGF lesion did not affect NKCC1 levels of the
prelimbic cortex at adults as detected by immunofluorescence.
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Figure 34: Immunofluorescence of NKCC1 in the Prelimbic Cortex at P90
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Figure 34. Immunofluorescence images showing the distribution of NKCC1 in the
prelimbic cortex of saline and NGF animals at P90. (A- C) Immunolabelling of NKCC1
in the prelimbic cortex of P90 saline at 10X (A), 20X (B), and enlarged 20X (C). (D- F)
Immunolabeling of NKCC1 in the prelimbic cortex of P90 NGF at 10X (D), 20X (E), and
enlarged 20X (F). At P90, NKCC1 immunolabelling is present in elongated apical
dendrites (white arrow), with punctate labelling on neuropil (white arrowhead). Scale bar,
100 µm.
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Figure 35: Immunofluorescence of NKCC1 in the Primary Motor Cortex at P90
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Figure 35. Immunofluorescence images showing the distribution of NKCC1 in the
primary motor cortex of saline and NGF animals at P90. (A- C) Immunolabelling of
NKCC1 in the primary motor cortex of P90 saline at 10X (A), 20X (B), and enlarged
20X (C). (D- F) Immunolabeling of NKCC1 in the primary motor cortex of P90 NGF at
10X (D), 20X (E), and enlarged 20X (F). At P90, NKCC1 in the primary motor cortex is
most predominant in perinuclear and cytoplasmic labelling (empty notched arrow).
Labelling is also present in elongated apical dendrites (white arrow), with few punctate
labelling on neuropil (white arrowhead). Scale bar, 100 µm.
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Figure 36: NKCC1 Fluorescence Intensity in the Prelimbic Cortex at P90
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Figure 36. NKCC1 fluorescence intensity in P90 NGF and control (SAL) comparison in
the prelimbic cortex. Bars indicate mean values for a group + SEM, points indicate
individual animal data (n=5; 4 sections per animal). (A- A’’) Representative NKCC1
fluorescence image of P90 saline and (B- B’’) P90 NGF in the prelimbic cortex used for
analysis, taken at 10X (A, B), magnified on Image J (A’, B’), and threshold applied to
highlight positive signal in white (A”, B”). Scale bar 100 µm. All imaging parameters
were kept consistent. (C) Mean P90 NKCC1 CTCF (not normalized) in the UPL, LPL,
and total PL. (D) Mean P90 NKCC1 CTCF in UPL, LPL, and total PL normalized to M1.
Normalized mean NKCC1 CTCF did not differ between groups. (E) Mean P90 NKCC1
CTCF in M1. Mean M1 NKCC1 CTCF did not differ between groups (p=0.771). UPL,
upper prelimbic (L2/3); LPL, lower prelimbic (L5/6); PL, total prelimbic cortex; M1,
primary motor cortex; a.u., arbitrary units.
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Chapter 5

5

Discussion

5.1 Levels of Parvalbumin and GAD67 Proteins in the
Prelimbic Cortex in Animals with Prefrontal Subplate
Lesion, and their Relevance to Schizophrenia
My results indicate that mean PV intensity in the total PL area was significantly
lower without changes in neuronal number in P23 rats following neonatal ablation of the
subplate. This is in agreement with a previous finding from our laboratory that neonatal
lesions of the prefrontal cortical subplate result in a decrease in PV protein levels in the
PL cortex using Western blot in adult rats (Desai et al. 2018). Neonatal hypoxiaischemia, for which subplate neurons are particularly susceptible to damage (Nguyen and
McQuillen 2010), in the developing rat visual cortex resulted in decreased PV protein
expression, but not neuronal density, in layer IV (Failor et al. 2010). Similarly, sensory
deprivation (for which information is primarily relayed through thalamocortical afferents)
in mice resulted in downregulation of PV protein expression in layer IV, the
thalamocortical recipient layer of the sensory cortex (Jiao et al. 2006). In human, studies
have consistently reported decreased PV expression levels in the dorsolateral PFC, a
homologue of medial PFC of rats, in post-mortem studies of schizophrenia (Hashimoto et
al. 2003; Glausier et al. 2014). Considering the crucial role PV neurons play in cognitive
functioning of the PFC, particularly in neuronal synchronization and E/I balance, it has
been proposed that decreased PV levels seen may drive certain cognitive symptoms of
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schizophrenia (Vierling-Claassen et al. 2008; Cardin et al. 2009; Sohal et al. 2009;
Williams and Boksa 2010; Selten et al. 2018). Nevertheless, it is important to note that
available human evidence is from post-mortem studies who chronically suffered the
disorder, while cognitive symptoms are core abnormalities of schizophrenia and
commonly seen during first episode patients. Therefore, presently it is not clear whether
PV levels are reduced in the PFC prior to the manifestation of symptoms such as in
prodromal cases. Interestingly, findings of Jiao et al. (2006) indicate that PV levels in
sensory cortex neurons are maintained via thalamocortical activity. Therefore, it was
hypothesized that in animals subjected to neonatal ablation of prefrontal cortical subplate,
a procedure well known to disconnect thalamocortical inputs, may show reduced PV
levels in the PL of the PFC at preadolescent periods, which are age windows comparable
to prodromal human cases. Considering the validity of our putative rat model to human
schizophrenia, my finding further validates the usefulness of our model to study a
potential mechanism relevant to the etiology of schizophrenia.
Interestingly, post-mortem studies of schizophrenia have identified that decreased
PV levels are most pronounced in upper layers of the dorsolateral PFC (Hashimoto et al.
2003; Glausier et al. 2014). In addition, a number of structural abnormalities in
schizophrenia, including dendritic spine loss and decrease in GABA transporter levels,
are limited to upper layers (Glantz and Lewis 2000; Volk et al. 2001; Glausier and Lewis
2013). Furthermore, damage to the subplate via hypoxia-ischemia in the sensory cortices
in rodents resulted in decreased PV in layer IV (Jiao et al. 2006). Therefore, I sought to
determine PV immunoreactivity in upper and lower layers separately as well. I found no
layer-specific alterations in PV expression, which may reflect the nature of the
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abnormality that occurred in thalamocortical innervation of these animals. It is possible
that in our model, with subplate ablation at P1 and P2, thalamocortical fibers destined to
upper layers had escaped the lesion. It is also important to note that in association cortices
such as the PFC, thalamocortical innervation is more widespread compared to sensory
cortices.
As expected, I also found no changes in PV-positive neuronal number in
neonatally subplate ablated animals. This is in agreement with post-mortem findings in
schizophrenia brains (Hashimoto et al. 2003; Glausier et al. 2014).
Visual cortex subplate lesioned animals have shown an increase in GAD67
protein expression throughout the cortical plate and underlying white matter in lesioned
animals near the injection site, persisting for at least 6 weeks after lesion in cats (Lein et
al. 1999). On the other hand, post-mortem studies of schizophrenia have consistently
reported decreased expression of GAD67 in a subpopulation of GABAergic interneurons
that co-express PV in the dorsolateral PFC (Hashimoto et al. 2003; Curley et al. 2011). In
the current study, GAD67 expression levels were not changed in PL cortex in postweanling animals that received neonatal prefrontal subplate-lesions. Although expected
based on the overwhelming implication of prefrontal GABA in cognitive function and
deficits in several cognitive and behavioral tests shown by this animal model (Rajakumar
et al. 2004; Lazar et al. 2008; Desai et al. 2018), my finding of unaffected GAD67 levels
agrees with Volk et al. (2003) that lesions of the mediodorsal thalamic nucleus, the
principal source of thalamocortical inputs to the PFC, failed to alter GAD67 mRNA
expression. GAD67 expression is activity-dependent (Lau and Murthy 2012) and
therefore, changes seen in the visual cortex and in elderly brains of schizophrenia patients
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could not be replicated in P23 post-weanling rats in my study. On the contrary,
considering the pattern of GAD67 decrease specifically in PV-expressing neurons in
post-mortem findings of schizophrenia, an analysis of GAD67 levels restricted to PVexpressing interneurons in this model warrants future studies.

5.2 Pattern of KCC2 Expression During Development
It has been shown in the cat primary visual cortex that a subplate lesion during
early developmental stages results in a delayed upregulation of KCC2 mRNA and a
resulting prolonged depolarizing effect of GABA in the thalamocortical recipient layer
IV of the visual cortex (Kanold and Shatz 2006). Thus, in the current study, it was
hypothesized that a subplate lesion in the developing PFC would also result in a delayed
KCC2 protein expression, which in normal animals correspond to the time when the
actions of GABA switch from depolarizing to hyperpolarizing (Bortone and Polleux
2009; Wang and Kriegstein 2011). However, the findings of the current study analysing
KCC2 immunolabeling in the PL cortex at several developmental time points indicated
that neonatal lesions of subplate of the developing PFC do not alter the temporal pattern
of upregulation of KCC2 protein. Since GABA changes relevant to schizophrenia and
thalamocortical innervation may have layer specificity, I sought to study upper and lower
layers separately. I did not find any layer-specific differences between subplate-lesioned
NGF animals and saline-infused control animals in KCC2 protein levels as detected by
immunofluorescence.
Several mechanisms of KCC2 regulation on both the transcriptional and posttranslational levels have been identified. For example, in mature neurons, brain-derived
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neurotrophic factor (BDNF) decreased KCC2 mRNA and protein, levels of tyrosinephosphorylation, and efficiency of membrane-insertion and stability of KCC2 (Rivera et
al. 2002; Rivera et al. 2004; Wake et al. 2007; Shulga et al. 2008; Boulenguez et al.
2010). In line with these findings, subplate lesions in the developing visual cortex have
shown a substantial increase in BDNF mRNA in all layers of the cortical plate, including
layer IV (Lein et al. 1999), providing a framework for a potential mechanism of altered
KCC2 levels as a result of subplate ablation. Investigation of BDNF levels in the PL
cortex following prefrontal cortical subplate ablation might be informative in this regard.
In addition to transcription and translation, phosphorylation of KCC2 protein at
various residues and transmembrane domains have been shown to differentially affect
KCC2 ion-transport function, membrane stability, and surface expression. For example,
age-dependent changes in phosphorylation of the carboxy-terminal threonine residues
Thr906 and Thr1007 have been identified. In immature neurons, inhibitory phosphorylation
of Thr906 and Thr1007 maintains a depolarizing GABAergic response by decreasing the
membrane pool of KCC2 (Rinehart et al. 2009; Friedel et al. 2015; Heubl et al. 2017),
while dephosphorylation of these residues were found to occur in parallel with the GABA
switch in more mature neurons in vivo, rendering the KCC2 protein active (Watanabe et
al. 2019). While the carboxy-terminal of the KCC2 protein was identified to play a
significant role in membrane stability and activity, the amino-terminal has been identified
to be essential for plasma membrane delivery (Côme et al. 2019). Deletion of the aminoterminal of the KCC2 protein inhibited its ion-transport activity without affecting the
surface expression of KCC2 (Li et al. 2007). Furthermore, studies have found an agedependent oligomerization of the KCC2 protein, a process thought to enhance KCC2 ion-
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transport activity (Medina et al. 2014). While immature brains were characterized by
higher content of KCC2 monomers and dimers, adult brains produced mostly oligomeric
forms of KCC2 (Medina et al. 2014). Membrane insertion of KCC2 is facilitated by
dimerization, while dimerization of KCC2 is facilitated by BDNF (Medina et al. 2014).
KCC2 proteins in the plasma membrane have a tendency to form clusters on the plasma
membrane, and it has also been shown that prevention of this clustering and decreased
function of KCC2 are tightly correlated (Watanabe et al. 2009), as well as a correlation
between decreased KCC2 oligomerization and reduced KCC2 transport activity in adult
tissue (Watanabe et al. 2009; Mahadevan et al. 2014). These findings suggest that despite
expression of KCC2 protein in neurons, several post-translational modifications such as
phosphorylation, oligomerization and clustering may affect membrane insertion, stability,
and hence, function of KCC2. Clearly, further studies of these properties are needed
before concluding on the role of KCC2 in the development of abnormalities in this
animal model with neonatal lesions of prefrontal cortical subplate.
Interestingly, KCC2 signal was detected for longer durations at excitatory
compared with inhibitory synapses, suggesting that KCC2 proteins escape clusters faster
at inhibitory synapses than at excitatory synapses, reflecting weaker molecular restraints
at inhibitory synapses (Chamma et al. 2013). Weaker molecular restraints at inhibitory
synapses may predispose GABAergic interneuron transmission to greater insult in
situations of KCC2 dysregulation. In the wild-type animal, the majority of KCC2
expression of pyramidal cells is localized on the somatic and dendritic membranes,
receiving inhibitory transmission from PV-expressing basket cells (Szabadics et al.
2006). Since the synaptic clustering of KCC2 is regulated on the plasma membrane by
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lateral diffusion and endocytosis (resulting in the recycling of transporters), which take
milliseconds to seconds and minutes, respectively (Côme et al. 2019), dysregulation of
KCC2 on the plasma membrane by factors such as increased BDNF or other neuronal
injury that result in cluster escape may not be detectable by the immunohistochemical
approach used in this study.
On the other hand, fluorescence signal in the current study was quantified as a
measure of integrated density, which accounts for both the relative size of fluorescence
signal in the area as well as the intensity per pixel analyzed. For the purpose of the
immediate research question (i.e. Is there a difference in KCC2 expression in the
prelimbic cortex of NGF animals compared to saline?), this was an appropriate method.
However, it is possible that subcellular KCC2 expression and localization patterns are
changed in lesioned animals, while total protein expression (whether it is clustering at or
near the synapse, expression in the plasma membrane, or submembrane reservoir), are
not. Quantification of fluorescence signal using the method employed would not be able
to detect subcellular changes in KCC2 expression, only changes in overall cellular and
neuropil intensity.
Kanold et al. (2006) found a continued depolarizing effect of GABA in layer IV
of the visual cortex in adult cats, along with a significant decrease in KCC2 mRNA
following neonatal ablation of subplate layer of the visual cortex. However, these authors
did not assess NKCC1 levels in the visual cortex in these animals. Given that KCC2 and
NKCC1 act cooperatively to establish a ratio in order to determine the net effect of
GABAA receptor activation, theoretically, a decrease in both KCC2 and NKCC1
expression simultaneously may not cause any functional changes in GABA polarity.
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Findings of Kanold and Shatz (2006) therefore imply that NKCC1 likely not affected by
the subplate lesion. My results also did not find any layer-specific or global differences in
NKCC1 protein expression in the PL cortex of subplate-lesioned animals compared to
their saline control counterparts.
The net effect of activation of GABAA receptors depend on the gradient of
chloride ions across the membrane, which is critically modulated by the net balance
between KCC2 and NKCC1. Therefore, both expression of these proteins, as well as
activity, can influence the intracellular chloride concentration and thus affect GABA
polarity. Future studies should assess GABA receptor function employing patch-clamp
electrophysiology in these animals.

5.3 Would Differences in Thalamocortical Innervation
Patterns between Primary Sensory and Association
Cortices affect GABA Maturation?
In addition to considerations of post-translational regulation of the KCC2 protein,
the contrasting results of a visual cortical subplate lesion and prefrontal cortical subplate
lesion in findings of KCC2 expression may be explained by differences in
thalamocortical circuitry. PV interneurons mediate the feedforward inhibition in
thalamocortical pathways for both the sensory and prefrontal cortices. However, while
there exists a distinct thalamocortical recipient layer IV in the sensory cortices, the
mediodorsal thalamus is a higher-order thalamic nucleus that does not synapse onto a
specific target layer but terminates wide-spread within the medial PFC (Delevich et al.
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2015; Collins et al. 2018). Nevertheless, many studies assume that layer III function of
the medial PFC is mainly influenced by the medial dorsal thalamus-driven feedforward
inhibition (Delevich et al. 2015; Collins et al. 2018). Further, differences in
thalamocortical inputs in the sensory areas compared to prefrontal cortices have been
identified (Delevich et al. 2015; Collins et al. 2018). Thalamocortical projections to layer
IV of sensory cortices are considered “driver” inputs, which constitute the main
information bearing pathway that influences the response properties of the postsynaptic
neuron (Viaene et al. 2011). While “driver” sensory thalamocortical synapses have higher
release probability and reliably drive action potentials to drive activity patterning (Collins
et al. 2018), mediodorsal thalamocortical projections have been suggested to take
“modulator” characteristics, which alter the gain of signal transmission in a statedependent manner (Bickford 2015; Schmitt et al. 2017). Further, the strength and release
probability of thalamocortical synapses onto PV neurons is not significantly different
than onto nearby pyramidal neurons in the mediodorsal thalamus-PFC pathway, while
thalamocortical synapses onto inhibitory cells of the primary sensory cortices is 3-4 times
stronger with a greater release probability than onto local pyramidal neurons (Delevich et
al. 2015). The higher release probability and stronger synapsing patterns of
thalamocortical afferents onto interneurons in the primary sensory cortices may thus
predispose inhibitory neurons in the visual cortex to greater insult by lesioning the
subplate than in the current mediodorsal thalamus-PFC pathway. The differences in the
inherent nature of these two pathways may contribute to differential results found in the
current study and in studies of sensory cortex subplate lesions.
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While studies have consistently found decreased volume and cell density in the
mediodorsal thalamus in schizophrenia (Shimizu et al. 2008; Buchmann et al. 2014), the
extents of affected thalamocortical connectivity in schizophrenia may not be as straight
forward as the above thalamus or thalamocortical lesion studies suggest. For example, a
large-scale fMRI study of 90 patients and 90 controls found that control subjects with the
lowest prefrontal-thalamic coupling showed the highest thalamo-sensory-motor coupling.
Schizophrenia patients showed a drop in this relationship, suggesting that functional
interactions between large-scale thalamocortical systems may be affected in
schizophrenia (Anticevic et al. 2014).

5.4 Implications and Significance of the Current Findings
We found a significant decrease in PV expression levels across the entire
prelimbic cortex. As PV interneurons are the primary target for thalamocortical afferents
in the mediodorsal thalamic-prefrontal cortex pathway and these PV interneurons play a
significant role in fine-tuning pyramidal outputs, the E/I balance of these prefrontal
subplate lesioned animals may be distorted. This is supported by findings of increased
behavioral abnormalities in prefrontal cortical subplate-lesion animal model from our
laboratory in previous studies (Rajakumar et al. 2004; Lazar et al. 2008; Desai et al.
2018).
Using the same subplate lesion model, we did not find any changes in the
developmental expression of KCC2 protein in the PL cortex. Thus, the findings of this
study did not support our original prediction and showed that protein levels in the plasma
membrane and neuropil were not significantly altered in prefrontal-subplate lesioned

105

animals. However, considering that KCC2 function is regulated by various posttranslational mechanisms, it is to be elucidated whether there are changes in subcellular
KCC2 expression patterns and function as a result of prefrontal subplate lesions.
Altogether, the current findings suggest that lesion of the developing prefrontal cortical
subplate does not alter surface expression of KCC2 in the PL cortex, but its effects on the
functional activity of KCC2 is to be further studied.
Further, the findings of the current study could highlight the significance of
sensory information for proper GABA maturation of the somatosensory cortex. Sensory
deprivation has been shown to produce similar GABA deficits as in the visual cortex
subplate lesion animals (Jiao et al. 2006). While the majority of inputs from
thalamocortical afferents to sensory cortex layer IV are sensory information (compared to
sensori-motor feedback to layer I), the mediodorsal thalamus-PFC pathway integrates
information from various structures and areas of the brain due to its nature as an
association cortex. This integrative role of PFC thalamic inputs, reflected in the disynaptic nature of PFC cortico-thalamo-cortical pathways, may further distinguish the
types of information relayed by the thalamic afferents to the visual cortex compared to
the prefrontal cortex. The difference in the “driver” characterized thalamocortical inputs
to the sensory cortices and “modulator” inputs to the prefrontal cortex may provide
further support for the significance of direct, “driver” type information relay to the cortex
for GABA maturation in the visual cortex, suggesting that it is the type of information
that is relayed (“driver” type sensory information), rather than the physical pathfinding of
thalamocortical axons and resulting synaptic changes, that are significant for proper
GABA maturation, at least in the visual cortex.
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5.5 Limitations and Future Directions
Specific precautions were taken to control for technical variability in data
acquisition and analysis. For example, rat pups were chosen from various litters to
control for litter effects (see Methods). Chosen pups were injected in small batches of 4-5
pups at a time for a maximum of 5-6 minutes to minimize effects of maternal separation,
which have been shown to inhibit membrane KCC2 expression as a model of neglect in
rat pups (Furukawa et al. 2017). Injected pups then were quickly returned to mothers to
be kept together until weaning around P21. P23 was selected to reflect the preadolescent
period of human prodromal phase in schizophrenia, while early enough to minimize
activity-dependent changes due to differential vulnerability to environmental stress in this
animal model. Perfusions of animals for study of each time point was done on the same
day and kept in post-fixative, cryoprotective solution, and storage for comparable times.
Samples to be compared at each time point were sectioned upon cryoprotection within 23 days, and immunofluorescence was conducted concurrently from a master mix for all
sections to be compared within each timepoint to reduce batch effects. Primary antibodies
used in this study were selected based on extensive use and validation in our laboratory
along with primary antibody omission controls (Rajakumar et al. 1994). I also used the
primary motor cortex (M1), an area present in the same sections of the PL cortex, as a
built-in technical control, as subplate lesion of the developing prefrontal cortex was
unlikely to affect M1. Despite the steps taken to minimize variability in data, several
findings in the current study violated Levene’s test of homogeneity in variance based on
mean (specifically, PV prelimbic results but not motor cortex results (Figures 8 and 9),
normalized P5 KCC2 prelimbic results but not motor cortex results (Figure 15D), and
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P11 NKCC1 motor cortex results (Figure 32, see Appendix D 3)). It is well known that
various factors can influence quantitative accuracy in fluorescent techniques, such as
temperature, pH, and incubation periods. There also exists a non-linear relationship
between light absorption and fluorescence emission in cases of smaller absorption values
(Perkin Elmer, 2000). Thus, the variability in the PV, P5 KCC2, and P11 NKCC1 M1
data could, in part, reflect the nature of the technique of choice. Immunofluorescence
requires a number of amplification steps, which may introduce additional levels for
potential variability in fluorescent signal and intensity between sections, despite
controlling for this variability with normalization of prelimbic results to M1 results from
the same section.
We only compared immunofluorescence intensity signals among samples
processed in the same batch of experiments due to the inherent variability as detailed
above. As a consequence, groups across different time points cannot be compared.
Technical aspects limited the number of sections/samples that could be run in any given
experimental batch. As the focal research question revolved around the difference
between groups at a certain time point, groups in a specific time point (i.e. NGF and
saline sections per given time point per antibody) were run in parallel. As the
developmental expression of both KCC2 and NKCC1 in the cortex have been extensively
characterized in existing literature (Gerald H. Clayton et al. 1998; Li et al. 2002; Wang et
al. 2002; Stein et al. 2004; Dzhala et al. 2005; Szabadics et al. 2006; Kovács et al. 2014;
Sánchez Fernández and Loddenkemper 2014; Amadeo et al. 2018), it was determined
that sections per time point would be run in parallel to investigate the direct research
question at hand.
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Future studies should utilize electrophysiology to determine the effects of a
prefrontal subplate lesion directly on the GABA polarity, which is predicted to be altered
by changes in KCC2 functional impairment. Although KCC2 expression on plasma
membranes and neuropil of prelimbic cortical neurons were unaffected in subplate
lesioned rats as detected by immunofluorescence, as mentioned above, there are several
regulatory mechanisms that differentially affect surface expression and function of
KCC2. Further, these studies may investigate the inhibitory transmission strength by PV
interneurons onto pyramidal neurons in the PL cortex to determine the functional
significance of decreased PV expression.
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Appendices
Appendix A: Results of Two-way ANOVA, Independent t-test, and Descriptive
Statistics for Parvalbumin CTCF and Cell Count by Group and PL Area
Table A 1
Results of Independent t-test and Descriptive Statistics for Parvalbumin CTCF in the
Primary Motor Cortex by Group
Group

95% CI

Saline
CTCF

NGF

For Mean

M

SD

n

M

SD

n Difference

3912.745

1790.592

5

4662.621

765.421

5

-2758.110,
1258.358

t

df

-0.861

8

* p < .05.
Table A 2
Two-way ANOVA Results and Descriptive Statistics for Normalized Parvalbumin
CTCF by Group and PL Area
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

1.696

0.642

5

1.040

0.249

5

LPL

1.769

0.531

5

1.161

0.227

5

Total

1.732

0.557

10

1.101

0.234

10

Source

SS

df

MS

F

Group

1.995

1

1.995

9.871*

Area

0.047

1

0.047

0.232

Group*Area

0.003

1

0.003

0.015

Error

3.234

16

0.202

Note. R2 =.387, adj. R2 = .273. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
and Total, total prelimbic cortex.
* p <.05
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Table A 3
Comparison of Mean Differences in Normalized Parvalbumin CTCF of Overall PL
Cortex by Group
Comparison
SAL vs. NGF

Estimated Mean

Standard Error of

Bonferroni Adjusted

Difference

Difference

95% CI

0.632*

0.201

0.205, 1.058

Note. SAL, saline.
* p <.05, where p-values are adjusted using the Bonferroni method.

Table A 4
Two-way ANOVA Results and Descriptive Statistics for Normalized Parvalbumin Cell
Count by Group and Layer-Specific PL Area (Upper and Lower)
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

0.637

0.302

5

0.357

0.156

5

LPL

0.618

0.277

5

0.501

0.155

5

Total

0.628

0.273

10

0.429

0.165

10

Source

SS

df

MS

F

Group

0.198

1

0.298

3.658

Area

0.019

1

0.019

0.360

Group*Area

0.034

1

0.034

0.622

Error

0.864

16

0.054

Note. R2 =.225, adj. R2 = .079. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
Total, average of UPL and LPL.
* p <.05
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Table A 5
Results of Independent t-test and Descriptive Statistics for Parvalbumin Cell Count in
the Total Prelimbic Cortex by Group
Group

95% CI

Saline
Count

NGF

For Mean

M

SD

n

M

SD

n

Difference

t

df

1.370

0.745

5

0.862

0.299

5

-0.402, 1.418

1.414

5.257

* p < .05.

Appendix B: Results of Two-way ANOVA, Independent t-test, and Descriptive
Statistics for GAD67 CTCF and Cell Count by Group and PL Area
Table B 1
Results of Independent t-test and Descriptive Statistics for GAD67 CTCF in the
Primary Motor Cortex by Group
Group

95% CI

Saline
CTCF

NGF

For Mean

M

SD

n

M

SD

n Difference

9805.906

2079.306

5

9362.626

1960.641

5

* p < .05.

-2504.011,
3390.571

t

df

0.347

8
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Table B 2
Two-way ANOVA Results and Descriptive Statistics for Normalized GAD67 CTCF by
Group and Prelimbic Area
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

1.195

0.213

5

1.143

0.223

5

LPL

1.105

0.151

5

1.131

0.316

5

Total

1.150

0.180

10

1.137

0.258

10

Source

SS

df

MS

F

Group

0.001

1

0.001

0.016

Area

0.013

1

0.013

0.239

Group*Area

0.008

1

0.008

0.141

Error

0.869

16

0.054

Note. R2 =.024, adj. R2 = -.159. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
and Total, overall prelimbic cortex.
* p <.05
Table B 3
Two-way ANOVA Results and Descriptive Statistics for Normalized GAD67 Cell Count
by Group and PL Area
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

0.717

0.112

5

0.607

0.165

5

LPL

0.793

0.207

5

0.644

0.184

5

Total

0.755

0.162

10

0.625

0.166

10

Source

SS

df

MS

F

Group

0.084

1

0.084

2.888

Area

0.016

1

0.016

0.540

Group*Area

0.002

1

0.002

0.063

Error

0.466

16

0.029

Note. R2 =.179, adj. R2 = .025. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
Total, as averaged by ANOVA.
* p <.05
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Table B 4
Results of independent t-test and Descriptive Statistics for GAD67 Cell Count in the
Total PL Cortex by Group
Group

95% CI

Saline
Count

NGF

For Mean

M

SD

n

M

SD

n

Difference

1.647

0.295

5

1.396

0.510

5

-0.366, 0.849

t

df

0.917

8

* p < .05.

Appendix C: Results of Two-way ANOVA, Independent t-test, and Descriptive
Statistics for KCC2 CTCF and Cell Count by Group and PL Area
Table C 1. Results of Independent t-test and Descriptive Statistics for KCC2 CTCF in the Primary Motor Cortex by Group at P5
Results of Independent t-test and Descriptive Statistics for KCC2 CTCF in the Primary
Motor Cortex by Group at P5
Group

95% CI

Saline
CTCF

NGF

For Mean

M

SD

n

M

SD

n Difference

1258.290

706.741

5

1214.816

523.111

5

-2504.011,
3390.571

t

df

0.111

8

* p < .05.
Table C 2. Results of Independent t-test and Descriptive Statistics for KCC2 CTCF in the Primary Motor Cortex by Group at P8
Results of Independent t-test and Descriptive Statistics for KCC2 CTCF in the Primary
Motor Cortex by Group at P8
Group

95% CI

Saline
CTCF

NGF

For Mean

M

SD

n

M

SD

n Difference

470.689

184.282

5

457.696

303.285

5

* p < .05.

-2504.011,
3390.571

t

df

0.082

8
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Table C 3. Results of Independent t-test and Descriptive Statistics for KCC2 CTCF in the Primary Motor Cortex by Group at P11
Results of Independent t-test and Descriptive Statistics for KCC2 CTCF in the Primary
Motor Cortex by Group at P11
Group

95% CI

Saline
CTCF

NGF

For Mean

M

SD

n

M

SD

n Difference

362.512

69.231

5

423.438

65.924

5

-159.514,
37.661

t

df

-1.425

8

* p < .05.
Table C 4. Results of Independent t-test and Descriptive Statistics for KCC2 CTCF in the Primary Motor Cortex by Group at P90
Results of Independent t-test and Descriptive Statistics for KCC2 CTCF in the Primary
Motor Cortex by Group at P90
Group

95% CI

Saline
CTCF

NGF

For Mean

M

SD

n

M

SD

n Difference

263.096

99.045

5

273.277

140.882

5

* p < .05.

-187.781,
167.419

t

df

-0.132

8
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Table C 5
Two-way ANOVA Results and Descriptive Statistics for Normalized KCC2 CTCF by
Group and PL Area at P5
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

0.631

0.178

5

0.815

0.358

5

LPL

0.509

0.060

5

0.614

0.251

5

Total

0.570

0.141

10

0.715

0.310

10

Source

SS

df

MS

F

Group

0.104

1

0.104

1.845

Area

0.131

1

0.131

2.309

Group*Area

0.008

1

0.008

0.137

Error

0.905

16

0.057

Note. R2 =.211, adj. R2 = .064. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
and Total, overall prelimbic cortex.
* p <.05
Table C 6
Two-way ANOVA Results and Descriptive Statistics for Normalized KCC2 CTCF by
Group and Prelimbic Area at P8
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

0.682

0.177

5

0.787

0.212

5

LPL

0.580

0.109

5

0.678

0.263

5

Total

0.631

0.149

10

0.733

0.232

10

Source

SS

df

MS

F

Group

0.052

1

0.052

1.318

Area

0.056

1

0.056

1.419

Group*Area

6.44E-5

1

6.44E-5

0.002

Error

0.629

16

0.039

Note. R2 =.146, adj. R2 =-.014. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
and Total, overall prelimbic cortex.
* p <.05
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Table C 7
Two-way ANOVA Results and Descriptive Statistics for Normalized KCC2 CTCF by
Group and Prelimbic Area at P11
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

0.838

0.267

5

1.047

0.443

5

LPL

0.746

0.224

5

0.675

0.219

5

Total

0.792

0.238

10

0.861

0.383

10

Source

SS

df

MS

F

Group

0.024

1

0.024

0.258

Area

0.269

1

0.269

2.938

Group*Area

0.098

1

0.098

1.072

Error

1.463

16

0.091

Note. R2 =.211, adj. R2 =.063. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
and Total, overall prelimbic cortex.
* p <.05
Table C 8
Two-way ANOVA Results and Descriptive Statistics for Normalized KCC2 CTCF by
Group and Prelimbic Area at P90
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

0.790

0.149

5

0.740

0.199

5

LPL

0.806

0.230

5

0.733

0.191

5

Total

0.798

0.183

10

0.736

0.184

10

Source

SS

df

MS

F

Group

0.019

1

0.019

0.500

Area

0.000

1

0.000

0.003

Group*Area

0.001

1

0.001

0.016

Error

1.463

16

0.091

Note. R2 =.031, adj. R2 =-.150. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
and Total, overall prelimbic cortex.
* p <.05
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Appendix D: Results of Two-way ANOVA, Independent t-test, and Descriptive
Statistics for NKCC1 CTCF and Cell Count by Group and PL Area
Table D 1. Results of Independent t-test and Descriptive Statistics for NKCC1 CTCF in the Primary Motor Cortex by Group at P5
Results of Independent t-test and Descriptive Statistics for NKCC1 CTCF in the
Primary Motor Cortex by Group at P5
Group

95% CI

Saline
CTCF

NGF

For Mean

M

SD

n

M

SD

n Difference

609.646

224.573

5

678.121

624.285

5

-752.675,
615.725

t

df

-0.231

8

* p < .05.
Table D 2. Results of Independent t-test and Descriptive Statistics for NKCC1 CTCF in the Primary Motor Cortex by Group at P8
Results of Independent t-test and Descriptive Statistics for NKCC1 CTCF in the
Primary Motor Cortex by Group at P8
Group

95% CI

Saline
CTCF

NGF

For Mean

M

SD

n

M

SD

n Difference

845.342

393.458

5

461.189

66.169

5

-27.309,
795.614

t

df

2.153

8

* p < .05.
Table D 3. Results of Independent t-test and Descriptive Statistics for NKCC1 CTCF in the Primary Motor Cortex by Group at P11
Results of Independent t-test and Descriptive Statistics for NKCC1 CTCF in the
Primary Motor Cortex by Group at P11
Group

95% CI

Saline
CTCF

NGF

For Mean

M

SD

n

M

SD

n Difference

525.806

178.760

5

517.713

57.406

5

* p < .05.

-210.245,
226.432

t

df

0.96

4.816
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Table D 4. Results of Independent t-test and Descriptive Statistics for NKCC1 CTCF in the Primary Motor Cortex by Group at P90
Results of Independent t-test and Descriptive Statistics for NKCC1 CTCF in the
Primary Motor Cortex by Group at P90
Group

95% CI

Saline
CTCF

NGF

For Mean

M

SD

n

M

SD

n Difference

443.390

210.019

5

405.923

184.049

5

-250.419,
325.554

t

df

0.301

8

* p < .05.

Table D 5
Two-way ANOVA Results and Descriptive Statistics for Normalized NKCC1 CTCF by
Group and Prelimbic Area at P5
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

0.776

0.195

5

0.854

0.261

5

LPL

0.788

0.237

5

0.848

0.246

5

Total

0.782

0.205

10

0.851

0.239

10

Source

SS

df

MS

F

Group

0.024

1

0.024

0.426

Area

6.70E-5

1

6.70E-5

0.001

Group*Area

0.000

1

0.000

0.007

Error

0.893

16

0.056

Note. R2 =.026, adj. R2 =-.156. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
and Total, overall prelimbic cortex.
* p <.05
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Table D 6
Two-way ANOVA Results and Descriptive Statistics for Normalized NKCC1 CTCF by
Group and Prelimbic Area at P8
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

0.818

0.401

5

1.063

0.156

5

LPL

0.690

0.292

5

0.808

0.163

5

Total

0.754

0.337

10

0.936

0.202

10

Source

SS

df

MS

F

Group

0.165

1

0.165

2.228

Area

0.183

1

0.183

2.465

Group*Area

0.020

1

0.020

0.275

Error

1.188

16

0.074

Note. R2 =.237, adj. R2 =.094. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
and Total, overall prelimbic cortex.
* p <.05
Table D 7
Two-way ANOVA Results and Descriptive Statistics for Normalized NKCC1 CTCF by
Group and Prelimbic Area at P11
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

0.864

0.283

5

1.016

0.351

5

LPL

0.841

0.218

5

0.919

0.333

5

Total

0.853

0.238

10

0.967

0.327

10

Source

SS

df

MS

F

Group

0.066

1

0.066

0.728

Area

0.018

1

0.018

0.197

Group*Area

0.007

1

0.007

0.077

Error

1.447

16

0.090

Note. R2 =.059, adj. R2 =-.118. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
and Total, overall prelimbic cortex.
* p <.05

140

Table D 8
Two-way ANOVA Results and Descriptive Statistics for Normalized NKCC1 CTCF by
Group and Prelimbic Area at P90
Saline

NGF

Area

Mean

SD

n

Mean

SD

n

UPL

0.643

0.252

5

0.724

0.354

5

LPL

0.642

0.230

5

0.732

0.274

5

Total

0.643

0.227

10

0.728

0.298

10

Source

SS

df

MS

F

Group

0.036

1

0.036

0.456

Area

6.28E-5

1

6.28E-5

0.001

Group*Area

0.000

1

0.000

0.001

Error

1.266

16

0.079

Note. R2 =.028, adj. R2 =-.154. UPL, upper prelimbic layer; LPL, lower prelimbic layer;
and Total, overall prelimbic cortex.
* p <.05
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